# Chapter 100: Cannabis Use Disorder

# The Biological and Neurological Basis of Cannabis Use Disorder

## Introduction

Cannabis Use Disorder (CUD) represents a significant and growing public health issue, characterized by a problematic pattern of cannabis use leading to clinically significant impairment or distress (Thakur et al., 2024; Jayaswal & Singh, 2025). Historically viewed through social and behavioral lenses, the contemporary understanding of CUD is increasingly grounded in biology, recognizing it as a chronic, relapsing brain disease (Miñarro López, 2021; Boylan, 2012; Bates, 2012). This disorder emerges from complex interactions between the psychoactive compounds in the cannabis plant and the intricate neurocircuitry of the human brain (Konopka, 2014). The primary psychoactive agent in cannabis is delta-9-tetrahydrocannabinol (THC), which is responsible for the sought-after effects of relaxation and euphoria, but also for its addictive potential and a range of adverse health consequences (Pytell & Rastegar, 2020; Latt et al., 2009).

The transition from recreational or experimental use to a compulsive, pathological state of dependence involves profound neurobiological adaptations (Jayaswal & Singh, 2025; Shazzad et al., 2014). These changes affect the brain's structure and function, altering the very systems responsible for reward, motivation, memory, and cognitive control (Miñarro López, 2021; Shirley, 2020). The discovery of the human body's endogenous cannabinoid system has provided a critical framework for understanding how exogenous cannabinoids like THC exert their powerful effects (Martin & Hall, 1997; Konopka, 2014). This system, with its specific receptors and endogenous ligands, is a primary target of THC, and its dysregulation is central to the development of CUD (Hoch & Preuss, 2019).

The biological underpinnings of CUD are not uniform across all individuals. Vulnerability is shaped by a confluence of genetic predispositions, environmental factors, and critical developmental periods, most notably adolescence (Williams, 2020; Grant & Bélanger, 2017). The developing adolescent brain appears uniquely susceptible to the neurotoxic effects of cannabis, with early and frequent use linked to lasting structural and functional changes that can increase the risk for other substance use disorders and severe mental illnesses, including psychosis (Grant & Bélanger, 2017; Murray et al., 2016; Crocker & Tibbo, 2015). Furthermore, the increasing potency of available cannabis products, characterized by high concentrations of THC and low levels of potentially protective compounds like cannabidiol (CBD), amplifies these risks (Di Forti et al., 2015; Murray et al., 2016; Ford et al., 2017).

This chapter aims to provide a comprehensive overview of the biological and neurological basis of Cannabis Use Disorder, drawing exclusively on the provided body of research. It will explore the neuropharmacology of the endocannabinoid system, the roles of key neurotransmitter pathways, and the specific brain regions and circuits implicated in the disorder. Furthermore, it will examine the genetic and molecular factors that confer vulnerability, the structural and functional brain changes observed in chronic users, and the critical impact of cannabis exposure during sensitive developmental windows. Finally, it will touch upon the biological basis of potential treatment strategies and highlight areas where future research is urgently needed to address this complex brain disorder.

## Neurobiological Systems

The development and maintenance of Cannabis Use Disorder are fundamentally rooted in the interaction of cannabis-derived compounds with the brain's endogenous neurochemical systems (Konopka, 2014). While the subjective experience of cannabis use involves euphoria and relaxation (Pytell & Rastegar, 2020), the underlying processes involve significant alterations in neurotransmission, receptor function, and circuit-level activity. At the core of this interaction is the endocannabinoid system, which is profoundly modulated by THC and serves as the primary gateway for the drug's psychoactive and addictive effects (Martin & Hall, 1997; Hoch & Preuss, 2019).

### The Endocannabinoid System

The human brain possesses a naturally occurring endocannabinoid system, which explains why externally administered cannabinoids have such direct and potent effects on brain function (Konopka, 2014). This system consists of cannabinoid receptors, endogenous ligands (endocannabinoids) like anandamide, and the enzymes responsible for their synthesis and degradation (Martin & Hall, 1997). Two primary types of cannabinoid receptors have been characterized: type-1 (CB1) and type-2 (CB2) (Konopka, 2014).

CB1 receptors are among the most abundant G-protein coupled receptors in the central nervous system (CNS) (Martin & Hall, 1997). Their widespread distribution provides insight into the diverse physiological and psychological effects of cannabis (Latt et al., 2009). CB1 receptors are densely located in brain regions critical for functions that are acutely affected by cannabis, such as cognition, memory, pain perception, and movement (Martin & Hall, 1997; Konopka, 2014). Key areas include the neocortex, hippocampus, basal ganglia, cerebellum, and amygdala (Konopka, 2014). The primary function of the endocannabinoid system is to modulate the release of other neurotransmitters through presynaptic mechanisms, acting as a retrograde signaling system that fine-tunes neuronal communication (Konopka, 2014). CB2 receptors, in contrast, are found primarily in the peripheral system, particularly on immune cells, though their presence in the CNS is also acknowledged (Konopka, 2014).

THC, the main psychoactive component of cannabis, acts as a partial agonist at CB1 receptors (Latt et al., 2009; Pytell & Rastegar, 2020). By binding to and activating these receptors, THC mimics the effects of endogenous cannabinoids but with greater potency and duration, leading to a widespread disruption of normal neurotransmitter modulation (Konopka, 2014). This overstimulation of the endocannabinoid system is believed to be the foundation for both the acute psychoactive effects and the long-term neuroadaptations that characterize CUD (Latt et al., 2009). Chronic, heavy exposure to THC can lead to a downregulation, or reduction in the number, of CB1 receptors as the brain attempts to adapt to the persistent overstimulation (Martin & Hall, 1997). This neuroadaptation is a key biological marker of tolerance, where increasingly larger doses of the drug are needed to achieve the initial effect, a hallmark of dependence (Shazzad et al., 2014; Hollister, 1998).

### Dopamine and the Reward Pathway

Like other substances of abuse, the addictive potential of cannabis is closely linked to its effects on the brain's reward system, a circuit in which the neurotransmitter dopamine plays a central role (Miñarro López, 2021; Batta, 2018). Addiction is increasingly understood as a disease affecting brain areas responsible for controlling behavior, particularly those involved in reward and motivation (Miñarro López, 2021; Shirley, 2020). The euphoric effects of cannabis are mediated through the stimulation of dopamine release in brain regions such as the nucleus accumbens (Delás et al., 2010; Batta, 2018).

THC's activation of CB1 receptors on GABAergic interneurons in the ventral tegmental area (VTA) inhibits the release of the inhibitory neurotransmitter GABA. This process, known as disinhibition, leads to an increase in the firing rate of dopamine neurons that project to the nucleus accumbens, resulting in a surge of dopamine (Konopka, 2014). This flood of dopamine is what produces the "high" or euphoria associated with drug use (Batta, 2018; Miñarro López, 2021). This powerful reinforcing effect makes the behavior more likely to be repeated (DuPont, 1998).

Over time, chronic cannabis use can lead to long-term alterations in the dopamine system (Hope, 1999). The brain's reward circuitry becomes dysregulated, leading to a state where the drug is no longer sought for its pleasurable effects (positive reinforcement) but rather to alleviate the negative emotional state and withdrawal symptoms that emerge during abstinence (negative reinforcement) (Kosten, 1992). This shift is central to the development of compulsive drug-seeking behavior (Gawin, 1991; Vanderschuren & Everitt, 2004). Craving, the intense desire for the drug, is a key clinical feature of CUD and is thought to be driven by these neuroadaptations in the reward pathway (Kosten, 1992; Kosten, 1992). High levels of craving are a strong predictor of relapse (Kosten, 1992).

### Other Neurotransmitter Systems

While the dopamine system is critical, the influence of the endocannabinoid system is far-reaching, modulating a variety of other neurotransmitter systems that are implicated in the pathophysiology of CUD.

**Glutamate:** As the brain's primary excitatory neurotransmitter, glutamate is essential for synaptic plasticity, learning, and memory. CB1 receptors are densely located on glutamatergic terminals, where they exert inhibitory control (Konopka, 2014). Disruption of this modulation by chronic THC exposure can impair cognitive functions, which is a well-documented consequence of long-term cannabis use (Pope & Yurgelun‐Todd, 2004; Martin & Hall, 1997). The dysregulation of glutamate homeostasis is also believed to contribute to the compulsive, drug-seeking behaviors seen in addiction (Zagorski, 2019). This is supported by preliminary evidence suggesting that N-acetylcysteine (NAC), a medication that helps restore normal glutamate levels, may show promise in reducing cannabis use, particularly in adolescents (Duncan, 2019; Zagorski, 2019).

**GABA:** Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the CNS. CB1 receptors are also present on GABAergic neurons, and their activation by THC can alter inhibitory tone throughout the brain (Konopka, 2014). This modulation is involved in the anxiolytic (anxiety-reducing) effects of cannabis, but its disruption can also contribute to withdrawal symptoms such as anxiety and irritability (Jayaswal & Singh, 2025; Hughes, 1991). The interaction between cannabis and alcohol, another substance that strongly affects the GABA system, is complex and can potentiate the effects of both substances (Drummond, 2002; Zacny, 1990).

**Norepinephrine:** The noradrenergic system is involved in arousal, stress, and the "fight or flight" response. The interaction between cannabinoids and this system may contribute to some of the cardiovascular effects of cannabis, such as tachycardia, as well as its influence on stress and anxiety (Broom & Yamamoto, 2007; Parrott, 1999).

In summary, the neurobiology of CUD is not driven by a single system but by a cascade of effects initiated by THC's action on the endocannabinoid system. This primary interaction leads to downstream dysregulation of dopamine, glutamate, GABA, and other critical neurotransmitter systems, ultimately rewiring the brain's motivational, cognitive, and emotional circuits to promote compulsive drug use (Miñarro López, 2021).

## Genetic and Molecular Basis

Cannabis Use Disorder, like other substance use disorders, is a complex trait that arises from the interplay of genetic vulnerabilities and environmental influences (Williams, 2020; Jayaswal & Singh, 2025). While exposure to cannabis is a prerequisite, not all users develop dependence, suggesting that individual biological differences play a crucial role in determining risk (Kalant, 1989). Research into the genetic and molecular underpinnings of CUD is essential for understanding who is most vulnerable and for developing targeted prevention and treatment strategies (Collier, 2006).

### Heritability and Genetic Epidemiology

Evidence from twin, family, and adoption studies consistently indicates that cannabis use, abuse, and dependence have significant heritable components (Collier, 2006; Griffith, 2018). Genetic epidemiology provides a powerful tool to disentangle the complex architecture of these behaviors, suggesting that different genetic factors may be involved at different stages of cannabis involvement, from initiation to dependence (Collier, 2006). For example, the genetic factors influencing the initial decision to try cannabis may be related to personality traits such as sensation-seeking or a predisposition to problem behavior (Collier, 2006; Barkus, 2008). In contrast, the transition from use to abuse and dependence may be more strongly influenced by genes that regulate an individual's sensitivity and reaction to the drug's effects (Collier, 2006).

Studies suggest that positive subjective reactions to cannabis, such as euphoria and happiness, are strongly associated with the subsequent development of dependence (Collier, 2006). Conversely, adverse effects like confusion, memory loss, or paranoia may be protective against developing dependence (Collier, 2006). These individual differences in drug response are likely mediated, in part, by genetic variation. This parallels findings in alcohol dependence, where a genetically determined flushing response can be protective, while a predisposition to euphoria increases risk (Collier, 2006). The heritability of CUD underscores that it is a medical condition with a biological basis, not simply a matter of personal choice or moral failing (Jayaswal & Singh, 2025; Kenadi, 2021).

### Candidate Genes and Potential Pathways

While the specific genes contributing to CUD risk are still being identified, research has focused on several plausible biological pathways. Given the central role of dopamine in reward and addiction, genes involved in dopamine signaling are considered strong candidates (Konopka, 2014). Genetic variations that alter the function of dopamine receptors, transporters, or metabolic enzymes could influence an individual's response to cannabis and their liability for dependence (Konopka, 2014). For instance, Konopka (2014) notes that individuals with altered genetic regulation of certain neurotransmitters, including dopamine, appear to be more vulnerable to developing psychosis following cannabis use, suggesting a gene-environment interaction.

Another critical area of investigation involves genes that code for components of the endocannabinoid system itself, such as the CB1 receptor (Konopka, 2014). Polymorphisms in the gene for the CB1 receptor could alter receptor density or function, thereby modifying an individual's sensitivity to THC and their risk for developing CUD. Similarly, genetic variations in the enzymes that synthesize or break down endogenous cannabinoids could influence the baseline tone of this system, potentially affecting vulnerability to the disruptive effects of exogenous cannabinoids (Martin & Hall, 1997).

The relationship between cannabis use and other psychiatric disorders, particularly schizophrenia, also points to a shared genetic vulnerability (Collier, 2006; Murray et al., 2016). The comorbidity between CUD and disorders like major depression and conduct disorder seems to result more from overlapping genetic influences than from a direct causal relationship (Collier, 2006). This suggests that some genes may confer a general risk for a spectrum of psychiatric and substance use disorders, rather than being specific to CUD alone (Collier, 2006; Spinazzola et al., 2023).

### Molecular Mechanisms of Neuroadaptation

At the molecular level, the transition to dependence involves long-term changes in brain cells that alter their structure and function (Miñarro López, 2021). These neuroadaptations are a form of neuroplasticity, driven by the chronic overstimulation of cannabinoid receptors by THC. One of the key molecular mechanisms is receptor downregulation, where the brain reduces the number of available CB1 receptors to compensate for their persistent activation (Martin & Hall, 1997). This process is a direct cause of tolerance, requiring the user to consume more cannabis to achieve the desired effects (Shazzad et al., 2014).

Furthermore, addiction is thought to involve long-term changes in gene expression, which may underlie the persistent nature of craving and the high risk of relapse (Hope, 1999). Chronic drug exposure, as demonstrated in models of cocaine addiction, can alter the transcription factors within neurons, leading to lasting changes in the synthesis of proteins that are critical for synaptic function and neuronal structure (Hope, 1999). These molecular alterations physically change neural circuits, making drug-seeking behavior compulsive and difficult to control even after long periods of abstinence (Gawin, 1991; Vanderschuren & Everitt, 2004).

The "gateway hypothesis," which posits that cannabis use increases the risk of using other illicit drugs like cocaine or heroin, may also have a molecular basis (Mandal, 2012; Williams, 2020). There is biological evidence for shared activation of mesolimbic dopamine pathways by both cannabis and opiates, which could represent a form of pharmacological priming, where exposure to one drug sensitizes the brain to the effects of another (Collier, 2006). However, twin studies have also suggested that this progression may be better explained by correlated risks—that is, shared genetic and environmental factors that influence the liability to use any drug—rather than a direct causal gateway effect (Collier, 2006; Klein, 2018).

In conclusion, the basis of CUD involves a strong genetic component that influences an individual's susceptibility at every stage, from initiation to dependence. This genetic vulnerability interacts with environmental factors and drug exposure to drive molecular changes in the brain, including receptor downregulation and altered gene expression. These neuroadaptations solidify the transition from voluntary use to a compulsive disorder of the brain (Miñarro López, 2021).

## Brain Structure and Function

Chronic cannabis use is associated with significant alterations in both the physical structure and functional organization of the brain (Konopka, 2014; Grant & Bélanger, 2017). These neuroanatomical and physiological changes are not merely correlational; they are believed to be the direct substrate for the cognitive impairments and behavioral changes that define Cannabis Use Disorder (CUD) (Andrade, 2016; Martin & Hall, 1997). While the field is still evolving, a consistent picture is emerging of how long-term, heavy cannabis consumption can reshape key neural circuits, particularly those integral to memory, emotional regulation, and executive control (Konopka, 2014).

### Structural Brain Changes

Neurobiological research indicates that individuals who use cannabis chronically and heavily exhibit altered brain structures compared to non-users (Konopka, 2014). These changes are particularly evident in regions with a high density of cannabinoid type-1 (CB1) receptors, which are the primary targets of THC (Martin & Hall, 1997; Konopka, 2014).

One of the most consistently implicated brain regions is the hippocampus (Konopka, 2014). The hippocampus is a structure critical for the formation and retrieval of episodic memories (Budson & Kensinger, 2023). A longitudinal study following individuals from adolescence to midlife found that long-term, persistent cannabis use was associated with smaller hippocampal volume at age 45 (Meier et al., 2022). This structural deficit is particularly concerning because smaller hippocampal volume in midlife is a known risk factor for the later development of dementia (Meier et al., 2022). This finding provides a direct anatomical link between chronic cannabis exposure and a key marker of brain aging and cognitive vulnerability.

Other brain regions implicated in structural changes include the amygdala and the frontal lobes (Konopka, 2014). The amygdala is central to processing emotions, particularly fear and anxiety, while the frontal lobes, specifically the prefrontal cortex, are responsible for executive functions such as decision-making, impulse control, and planning (Konopka, 2014). Although direct evidence from the provided sources is limited for cannabis, studies on other substances of abuse, like cocaine, have shown that chronic use is associated with structural changes in these prefrontal areas, which may promote a premature aging of the brain (Herdener et al., 2015). Given the overlapping neurocircuitry of addiction, it is plausible that similar structural alterations contribute to the loss of self-control seen in CUD (Goldstein, 2008).

### Functional Consequences: Cognitive Impairment

The structural alterations associated with chronic cannabis use are paralleled by profound functional consequences, most notably in the domain of cognition (Andrade, 2016). Cognitive impairment, especially affecting attention and memory, is one of the main acute adverse effects of cannabis (Martin & Hall, 1997). However, a significant body of evidence suggests that these deficits can persist well beyond the period of acute intoxication, constituting a residual effect of long-term use (Pope & Yurgelun‐Todd, 2004; Hollister, 1998).

**Memory and Learning:** The most well-documented cognitive deficit is in the realm of short-term memory and verbal learning (Martin & Hall, 1997; Pope & Yurgelun‐Todd, 2004; Andrade, 2016). Chronic marijuana users consistently underperform on memory and cognitive tasks relative to non-users (Konopka, 2014). For example, a study of college students who were heavy cannabis users showed enduring cognitive deficits even after a period of abstinence (Saitz, 2002; Pope & Yurgelun‐Todd, 2004). These impairments in memory formation and retrieval are directly linked to the disruption of hippocampal function, the same region where structural volume loss has been observed (Meier et al., 2022; Konopka, 2014). Memory impairment has been reported to last for up to one month after the last use of cannabis (Neuspiel, 2012).

**Attention and Executive Functions:** Beyond memory, chronic cannabis use impairs other higher-order cognitive processes governed by the frontal lobes (Konopka, 2014). These include deficits in attention, concentration, problem-solving, and decision-making (Neuspiel, 2012; Rathee, 2021). This cognitive decline can have tangible real-world consequences, contributing to diminished school performance, reduced educational attainment, and impaired occupational performance (Grant & Bélanger, 2017; van Ours & Williams, 2014). The impairment of psychomotor performance and reaction time also increases the risk of motor vehicle accidents (Andrade, 2016; Ménétrey et al., 2001; Sewell et al., 2009). The executive deficits are thought to stem from altered function in the prefrontal cortex, a region critical for goal-directed behavior and inhibiting impulsive actions (Konopka, 2014).

### Neural Circuits and Functional Connectivity

Cannabis Use Disorder can be conceptualized as a disease of neural circuits. The behavioral symptoms of addiction—compulsive use, loss of control, and a negative emotional state during withdrawal—arise from dysregulated communication within and between large-scale brain networks (Miñarro López, 2021). The primary psychoactive effects of cannabis are achieved through the binding of THC to CB1 receptors, which are densely populated in the hippocampus, neocortex, basal ganglia, and cerebellum (Konopka, 2014). Chronic THC exposure alters the functional connectivity of these regions.

The circuit connecting the VTA to the nucleus accumbens is central to reward and reinforcement, and its dysregulation by cannabis drives the motivation for continued use (Delás et al., 2010). The prefrontal cortex, which normally exerts top-down control over these subcortical reward regions, becomes compromised in addiction (Goldstein, 2008). This weakening of prefrontal control over the reward circuit is a key neurological feature that underlies the transition from voluntary to compulsive drug-seeking (Vanderschuren & Everitt, 2004).

Furthermore, the interplay between the amygdala, hippocampus, and prefrontal cortex is critical for emotional regulation and memory (Konopka, 2014). Chronic cannabis use disrupts these circuits, which may explain the high comorbidity of CUD with mood and anxiety disorders (Lowe et al., 2024; Strong et al., 2025). The anxiogenic or anxiolytic effects of cannabis can vary between individuals and are likely related to dose, chronicity of use, and the specific state of these interconnected neural circuits (Konopka, 2014). Studies on cannabis abuse have suggested it may blunt the brain's response to stimulant challenges, indicating a potential cross-substance alteration of brain metabolism and function (Roy‐Byrne, 2016).

In conclusion, the brain of an individual with CUD is structurally and functionally different from that of a non-user. Chronic exposure to THC leads to measurable changes, such as reduced hippocampal volume, and functional deficits in memory, attention, and executive control. These effects are the manifestation of disrupted neural circuits that prioritize drug-seeking over adaptive behaviors, solidifying the view of CUD as a disorder of the brain.

## Developmental Neurobiology

The timing of cannabis exposure is a critical determinant of its neurobiological and clinical impact. The human brain undergoes a prolonged period of maturation that extends from the prenatal period through adolescence and into the early twenties (Grant & Bélanger, 2017; Hurd et al., 2023). This developmental window is characterized by dynamic processes of synaptogenesis, pruning, and myelination, which sculpt the brain's final architecture and functional networks (French et al., 2015). The endocannabinoid system plays a crucial role in orchestrating these neurodevelopmental processes (Hurd et al., 2023). Consequently, exposure to exogenous cannabinoids like THC during these sensitive periods can disrupt normal brain development, leading to long-lasting or permanent alterations in brain structure and function (Grant & Bélanger, 2017; George & Vaccarino, 2015).

### Adolescent Vulnerability

Adolescence is a period of heightened vulnerability to the effects of cannabis (Grant & Bélanger, 2017; Crocker & Tibbo, 2015). This vulnerability is not merely behavioral, reflecting increased risk-taking and peer influence (Macdonald, 1988), but is deeply rooted in the ongoing maturation of the adolescent brain (Hurd et al., 2023; Li & Tao, 2024). The prefrontal cortex, which is responsible for executive functions like judgment and impulse control, is one of the last brain regions to fully mature, making adolescents neurobiologically predisposed to impulsive behaviors (Konopka, 2014).

Introducing THC during this critical period can cause functional and structural changes to the developing brain, leading to damage (Grant & Bélanger, 2017; George & Vaccarino, 2015). Research indicates that individuals who begin heavy marijuana use before the age of 17 are significantly more likely to abuse other substances later in life and may experience future cognitive difficulties, such as a lower IQ (Konopka, 2014). The developing brains of adolescents are particularly susceptible to the development of tobacco and nicotine dependence, and cannabis use can facilitate this process (Groner et al., 2015; Williams, 2020). Indeed, cannabis use during adolescence is strongly linked to the initiation and maintenance of tobacco smoking (Grant & Bélanger, 2017; Perriot et al., 2021). The risk of developing CUD itself is also higher the earlier that use is initiated (Latt et al., 2009; Copeland & Alperstein, 2016).

### Cannabis Use and the Risk of Psychosis

One of the most concerning consequences of adolescent cannabis use is its established link to an increased risk of developing psychotic disorders, including schizophrenia (Murray et al., 2016; Johnson‐Ferguson & Di Forti, 2021). There is now incontrovertible evidence for this association, which demonstrates a clear dose-response relationship: the earlier the onset of use, the higher the frequency of use, and the higher the potency of the cannabis, the greater the risk (Di Forti et al., 2015; Colizzi & Murray, 2018; Murray et al., 2016).

Cannabis use is considered a component cause of psychosis, meaning it can trigger the disorder in individuals who are already vulnerable due to genetic or other factors (Johnson‐Ferguson & Di Forti, 2021; Spinazzola et al., 2023). Adolescents may possess a greater biological risk than older individuals for developing psychotic disorders following cannabis abuse (Bartzatt, 2010; Drewe, 2003). Studies have shown that cannabis use can worsen the course of schizophrenia spectrum disorders (Bartzatt, 2010; Atakan, 2008) and can precipitate a transient, dose-dependent psychosis even in healthy individuals (Murray et al., 2016). Furthermore, up to one-third of individuals who experience a cannabis-induced psychosis may go on to receive a diagnosis of schizophrenia over time (Bramness, 2022).

The neurobiological mechanisms underlying this link are thought to involve the disruption of normal brain maturation processes by THC (French et al., 2015). High-potency cannabis, often referred to as "skunk," which is characterized by high levels of THC and a virtual absence of cannabidiol (CBD), carries the greatest risk (Di Forti et al., 2015; Murray et al., 2016). CBD may have antipsychotic and anxiolytic properties that can ameliorate some of THC's psychotogenic effects; its absence in modern cannabis strains may therefore magnify the potential for harm (Murray et al., 2016; Morgan, 2009). Synthetic cannabinoids, which are often full agonists at the CB1 receptor and significantly more potent than THC, also carry a very high risk for inducing psychosis (Murray et al., 2016; Tellioğlu & Çelebi, 2014).

### Prenatal Exposure

The developmental risks of cannabis exposure begin even before adolescence. THC readily crosses the placental barrier, exposing the fetus to its psychoactive effects (Delás et al., 2010; Rocha et al., 2017). Cannabis use during pregnancy is associated with adverse outcomes such as shortened gestation and low birth weight (Martin & Hall, 1997; Brown & Graves, 2013). More concerning are the potential long-term neurodevelopmental consequences. THC accumulates in breast milk at high concentrations, providing another route of exposure for the newborn (Delás et al., 2010). Prenatal cannabis exposure has been linked to compromised neurodevelopment, social adjustment, and vocational success later in life (Andrade, 2016). Studies have suggested subtle negative effects on neurobehavioral outcomes, including sleep disturbances, hyperactivity, inattention, and impaired visual problem-solving in children exposed in utero (Kozer & Koren, 2001; Hurd et al., 2023). These findings underscore that the vulnerability of the brain to cannabis is a continuum, starting from the earliest stages of its formation.

In summary, the developmental neurobiology of CUD highlights adolescence as a period of profound risk. Cannabis use during this time can derail critical brain maturation processes, leading to lasting cognitive deficits, an increased likelihood of addiction to cannabis and other substances, and a significantly elevated risk for severe psychiatric disorders like schizophrenia (George & Vaccarino, 2015; Grant & Bélanger, 2017; Li & Tao, 2024).

## Treatment Mechanisms

Developing effective treatments for Cannabis Use Disorder requires a deep understanding of the disorder's underlying biological mechanisms. Because CUD is a brain disease characterized by altered neurocircuitry and neurochemistry, interventions—whether pharmacological or psychosocial—must ultimately aim to reverse, compensate for, or manage these neurobiological changes (Miñarro López, 2021; Shirley, 2020). The chronic, relapsing nature of addiction highlights the persistence of these brain alterations, making long-term management a necessity (Boylan, 2012; Bates, 2012; Daley & Douaihy, 2019).

### Neuroplasticity and the Goal of Recovery

The brain changes induced by chronic drug use are a form of maladaptive neuroplasticity (Hope, 1999). Recovery, therefore, can be viewed as a process of harnessing the brain's capacity for adaptive neuroplasticity to unlearn addictive behaviors and establish new, healthier patterns (Miñarro López, 2021). Psychosocial interventions, such as cognitive-behavioral therapy (CBT), function by helping individuals retrain maladaptive neural circuits (Copeland & Alperstein, 2016). By teaching coping skills, altering expectancies, and restructuring thought patterns related to drug use, these therapies help to strengthen prefrontal cortical control over the subcortical reward regions that drive craving and compulsive behavior (Goldstein, 2008). Brief CBT and contingency management have been identified as effective strategies for CUD, demonstrating that behavioral interventions can produce meaningful clinical improvements (Copeland, 2012). Motivational interviewing is another key approach that helps move an individual through stages of change toward abstinence (Knapp & McCabe, 2022; Madukwe, 2013).

### Pharmacological Targets

Despite the clear biological basis of CUD, there are currently no medications that have been shown to be definitively effective or approved by regulatory bodies for its treatment (Pytell & Rastegar, 2020; Perriot et al., 2021; Zagorski, 2019). However, research continues to explore several promising pharmacological targets based on the neurobiology of the disorder.

**Modulating the Endocannabinoid System:** One logical approach is to directly target the endocannabinoid system. This can be done through several strategies:
*   **Cannabinoid Agonists (Replacement Therapy):** Similar to nicotine replacement therapy for smoking cessation or methadone for opioid dependence, this strategy involves administering a controlled dose of a cannabinoid agonist to reduce withdrawal symptoms and craving (Latt et al., 2009; Hughes, 1988). Early studies have explored synthetic THC (dronabinol) and the potent CB1 agonist nabilone, with some evidence that nabilone may show efficacy, although its high cost is a barrier (Zagorski, 2019).
*   **Cannabidiol (CBD):** Unlike THC, CBD is a non-psychoactive cannabinoid that has been implicated in a range of potential therapeutic effects (Goodpaster, 2025; Murray et al., 2016). Recent research suggests that CBD may be effective in reducing nicotine withdrawal severity and anxiety during abstinence from e-cigarettes, pointing to its potential utility in managing withdrawal from other substances (Gournay et al., 2023). Its anxiolytic properties may help manage the anxiety and irritability that are prominent features of cannabis withdrawal (Jayaswal & Singh, 2025; Hughes, 1991).
*   **Allosteric Modulators:** A novel approach involves using compounds that modulate the CB1 receptor without directly activating it. The neurosteroid pregnenolone was identified as an endogenous negative allosteric modulator of the CB1 receptor, capable of blocking some of THC's behavioral effects (Tomaselli, 2020). This has led to the development of synthetic analogues like AEF0117, which inhibit specific CB1 signaling pathways and can block THC-induced behaviors in animal models, representing a promising new therapeutic direction (Tomaselli, 2020).

**Targeting Downstream Neurotransmitter Systems:**
*   **Glutamate Modulation:** Given the evidence for glutamate dysregulation in addiction, medications that normalize glutamatergic function are of significant interest. N-acetylcysteine (NAC) is an over-the-counter antioxidant that helps restore glutamate homeostasis (Zagorski, 2019). Preliminary data suggest that NAC, when combined with behavioral therapy, may be particularly effective at promoting cannabis abstinence in adolescents and young adults (Duncan, 2019; Zagorski, 2019).
*   **Managing Withdrawal Symptoms:** A pragmatic approach involves using medications to target specific symptoms of cannabis withdrawal, such as insomnia, anxiety, and restlessness (Pytell & Rastegar, 2020; Jayaswal & Singh, 2025). Studies have shown that medications like the insomnia drug zolpidem, the anxiolytic buspirone, and the antihypertensive guanfacine can effectively manage these symptoms (Zagorski, 2019). However, simply alleviating withdrawal does not consistently translate into long-term abstinence, suggesting that addressing withdrawal is necessary but not sufficient for treating the core addiction (Zagorski, 2019). Gabapentin, an anticonvulsant, has also shown some potential in early studies for promoting abstinence in addition to reducing withdrawal (Zagorski, 2019).

The development of effective pharmacotherapies remains a crucial goal, as they could significantly enhance the efficacy of psychosocial treatments (Perriot et al., 2021). The challenge lies in finding compounds that can effectively normalize the complex neuroadaptations caused by chronic cannabis use without producing significant side effects or having abuse potential themselves (Pytell & Rastegar, 2020).

## Future Directions

While our understanding of the biological basis of Cannabis Use Disorder (CUD) has advanced significantly, numerous questions and challenges remain. The evolving landscape of cannabis use, including legalization, increasing potency, and the emergence of novel products, creates an urgent need for continued and expanded research (Chandy et al., 2023; Budney & Lile, 2009). The restrictions on research due to cannabis's legal status have historically hampered progress, leaving many critical areas under-explored (Chandy et al., 2023; Bartzatt, 2010).

A primary area for future investigation is the differential effects of various cannabinoids and their formulations (Budney & Lile, 2009). Most research has focused on THC, yet the cannabis plant contains over 100 other phytocannabinoids (Latt et al., 2009; Metrik, 2022). Cannabidiol (CBD) is of particular interest due to its non-psychoactive nature and potential therapeutic properties, which may counteract some of THC's negative effects (Murray et al., 2016; Morgan, 2009). Studies need to differentiate between the effects of high-THC/low-CBD strains, which dominate the recreational market, and other cannabinoid profiles (Goodpaster, 2025). Understanding the distinct neurobiological impacts of CBD, THC, and their interactions is crucial for both harm reduction and therapeutic development (Murray et al., 2016).

The proliferation of new cannabis products presents another challenge. Cannabis concentrates, such as butane hash oil or "dabs," which can contain THC concentrations up to 90%, are gaining popularity (Alzghari et al., 2017; Stogner & Miller, 2015). The toxicity and long-term health consequences of these high-potency products, including potential neurotoxicity and cardiotoxicity, are largely unknown and require urgent investigation (Alzghari et al., 2017). Similarly, synthetic cannabinoids ("Spice," "K2") represent a significant public health threat (Murray et al., 2016; Tellioğlu & Çelebi, 2014). These substances are often full agonists at the CB1 receptor and are far more potent than THC, leading to more severe complications, including psychosis, seizures, and death (Saputra & Amin, 2023; Hanson, 2011; Phillips et al., 2016). Research must keep pace with the ever-changing chemical composition of these illicit products (Hanson, 2011).

Further research is also needed to elucidate the long-term neurodevelopmental consequences of cannabis use. While the link between adolescent use and psychosis is well-established (Colizzi & Murray, 2018), the precise mechanisms and the full spectrum of risk require deeper exploration. Longitudinal studies are needed to track brain development in adolescent users and to determine the reversibility of cognitive deficits with prolonged abstinence (Pope & Yurgelun‐Todd, 2004; Meier et al., 2022). The specific impact of cannabis vaping, a rapidly emerging trend among youth, on respiratory and neurological health also needs to be clarified (Chadi et al., 2020; Fischer et al., 2015).

From a therapeutic standpoint, the development of effective pharmacotherapies for CUD is a major priority (Perriot et al., 2021). Larger, more robust clinical trials are needed to confirm the preliminary promise of agents like NAC and gabapentin and to explore novel targets like allosteric modulators of the CB1 receptor (Zagorski, 2019; Tomaselli, 2020). It may also be necessary to reconsider clinical trial endpoints; rather than focusing solely on complete abstinence, "harm reduction" outcomes, such as a reduction in the quantity or frequency of cannabis use, might reveal benefits from medications that were previously missed (Zagorski, 2019).

Finally, understanding the heterogeneity of CUD is crucial. Research should aim to identify biological subtypes of the disorder, potentially based on genetic risk profiles, patterns of comorbidity with other psychiatric conditions, or specific neurobiological signatures (Collier, 2006; Konopka, 2014). This would allow for a more personalized medicine approach, matching specific patient profiles to the most effective interventions, whether pharmacological or psychosocial. Addressing these unanswered questions will be essential for developing evidence-based public policies and effective clinical strategies to mitigate the harms associated with CUD.

## Conclusion

Cannabis Use Disorder is a complex brain disorder rooted in the profound and multifaceted interactions between exogenous cannabinoids and the body's endogenous neurobiological systems. The scientific evidence, though still developing, paints a clear picture of CUD not as a failure of willpower, but as a chronic, relapsing condition driven by adaptive changes in the brain (Miñarro López, 2021; Boylan, 2012). The primary psychoactive compound, THC, exerts its effects by hijacking the endocannabinoid system, a critical modulator of neuronal communication throughout the central nervous system (Konopka, 2014; Martin & Hall, 1997). This initial interaction triggers a cascade of downstream effects, most notably the dysregulation of the mesolimbic dopamine reward pathway, which underlies the reinforcing properties of the drug and the development of compulsive use (Delás et al., 2010; Batta, 2018).

Chronic exposure to cannabis induces lasting neuroadaptations, including the downregulation of CB1 receptors and potential long-term changes in gene expression, which manifest as tolerance, dependence, and a persistent withdrawal syndrome upon cessation (Martin & Hall, 1997; Hope, 1999). These neurobiological shifts are the substrate for the disorder's clinical presentation, from intense craving to significant cognitive impairments in memory, attention, and executive function (Pope & Yurgelun‐Todd, 2004; Meier et al., 2022). The brain's structural integrity can also be compromised, with long-term use linked to volumetric changes in critical regions like the hippocampus (Meier et al., 2022).

Vulnerability to CUD is not uniform; it is shaped by a complex interplay of genetic predispositions and environmental factors (Collier, 2006; Williams, 2020). The developmental stage at which exposure occurs is paramount. The adolescent brain, undergoing dynamic maturation, is uniquely susceptible to the disruptive effects of THC, with early and heavy use substantially increasing the risk for addiction, lasting cognitive deficits, and the precipitation of severe mental illnesses such as psychosis and schizophrenia (Grant & Bélanger, 2017; Murray et al., 2016; Johnson‐Ferguson & Di Forti, 2021).

Understanding these biological mechanisms is fundamental to the development of effective interventions. While psychosocial therapies aim to retrain maladaptive neural circuits through behavioral change, the search for effective pharmacotherapies continues, targeting the endocannabinoid system, downstream neurotransmitter pathways like glutamate, and the management of debilitating withdrawal symptoms (Zagorski, 2019; Perriot et al., 2021). As societal attitudes and legal frameworks surrounding cannabis continue to evolve, it is imperative that public discourse is informed by a clear, evidence-based understanding of the neurobiological realities of Cannabis Use Disorder. Continued research into these mechanisms is essential to protect public health, refine prevention strategies, and provide effective, biologically-informed care for the millions affected by this disorder globally.


## References

1. Acuff, S. F., & Strickland, J. C. (2025). Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target. Addiction. https://doi.org/10.1111/add.70048
2. Addicott, A. K., Gray, J. J., & Todd, B. L. (2009). Mood, Dietary Restraint, and Women's Smoking and Eating Urges. Women & Health. https://doi.org/10.1080/03630240903158396
3. Adenusi, A., Magacha, H. M., Nwaneki, C., Asifat, O., & Annor, E. (2023). Cannabis Use and Associated Gastrointestinal Disorders: A Literature Review. Cureus. https://doi.org/10.7759/cureus.41825
4. Aguilar, C. (2012). SUSTANCIAS NO ILEGALES UTILIZADAS COMO DROGAS: “INCIENSO”, “SALES DE BAÑO” Y OTRAS.. Revista Clínica Escuela de Medicina UCR-HSJD. https://doi.org/10.15517/rc_ucr-hsjd.v2i11.7975
5. Ahamed, M., Chhabra, K. G., Reche, A., & Paul, P. (2022). Tobacco cessation by prescription - A 180 degree turn. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/jfmpc.jfmpc_2414_21
6. Ahmed, F. A., & Peeran, S. W. (2016). Significance and determinants of tobacco use: A brief review. Dentistry and Medical Research. https://doi.org/10.4103/2348-1471.184726
7. Aigner, C., Zeillinger, V., Baur, K., Baranyi, R., & Grechenig, T. (2023). BreathIn – A Serious Game to Support Patients with Smoking Cessation. https://doi.org/10.1145/3608298.3608342
8. Ainsworth, D. S. B. (2014). Maternal drug abuse. https://doi.org/10.1002/9781118819494.ch10
9. Al-Tomma, E., Karbouj, G., Darkal, R., Shoujaa, A., & Najati, G. (2023). Why Students Smoke? A Scientific Research on College Students In Syria. Journal of Medical Case Reports and Case Series. https://doi.org/10.38207/jmcrcs/2023/may04070342
10. Albarracin, M. L. G., & Chaparro, P. (2018). Diabetes and Cannabis: Myth or Reality. Cardiology & Vascular Research. https://doi.org/10.33425/2639-8486.1008
11. Algalarrondo, O. (2014). De la consommation au sevrage (cannabis, cocaïne, amphétamines, héroïne), en milieu libre ou en milieu carcéral : prises en charge et rôle du pharmacien d'officine.
12. Aljamali, N. M., Al-Qraawy, W. K. N., & Helal, T. A. (2022). Review on carcinogens materials in chemical laboratories. International Journal of Molecular Biology and Biochemistry. https://doi.org/10.33545/26646501.2022.v4.i1a.26
13. Alonso, I. M., Meana, J. J., & Vargas, L. P. (1999). Nicotina y tabaquismo: nuevas perspectivas : avances en farmacología de drogodependencias.
14. Aloufi, N., Namkung, Y., Traboulsi, H., Wilson, E. T., Laporte, S. A., Kaplan, B. L., Ross, M. K., Nair, P., Eidelman, D. H., & Baglole, C. J. (2022). Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.852029
15. Alves, L. L., & Menezes, A. P. S. (2017). PREVALÊNCIA DE UTILIZAÇÃO DO ÁLCOOL NA ADOLESCÊNCIA E EFEITOS TOXICOLÓGICOS DE SEU ABUSO. ANAIS CONGREGA MIC - ISBN:978-65-86471-05-2  e  ANAIS  MIC JR. - ISBN:978-65-86471-06-9.
16. Alwi, V. A. P. (2020). makalah jenis jenis narkoba-vania. https://doi.org/10.31219/osf.io/7e5cj
17. Alzahrani, H. H., Alasmari, Y. M., Almutairi, N. A., Aldajani, S. G., Alanazi, F. O., Alsadiq, A. A., Alanazi, E. J., Moailo, H. A. A., Alotaibi, J. T., Alsubhi, A. M., Bagais, A. H., & Asfour, G. M. (2022). Pharmacological approach to smoking cessation and effective intervention models. International Journal of Community Medicine and Public Health. https://doi.org/10.18203/2394-6040.ijcmph20223567
18. Alzghari, S. K., Fung, V., Rickner, S. S., Chacko, L., & Fleming, S. W. (2017). To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates. Cureus. https://doi.org/10.7759/cureus.1676
19. Amor, M. A. B., Mabrouk, H., & Hellara, I. (2018). Vulnérabilité commune à la schizophrénie et au cannabis. Editions universitaires europeennes eBooks.
20. Andrade, C. (2016). Cannabis and Neuropsychiatry, 1: Benefits and Risks. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.16f10841
21. Andrews, D. A. (2010). Chapter 9 – Substance Abuse. https://doi.org/10.1016/b978-1-4224-6329-1.50014-2
22. Anta, R. M. O., Ortega, A. I. J., García, R. M. M., Mora, A. M. L., & Lozano-Estevan, M. D. C. (2021). Nutritional problems in smokers and passive smokers. Nutrición Hospitalaria. https://doi.org/10.20960/nh.03794
23. Arane, K., & Goldman, R. D. (2016). Electronic cigarettes and adolescents.. PubMed.
24. Arman, Z., Rorong, M. J., & Svinarky, I. (2021). PEMBINAAN ANCAMAN HUKUMAN PENYALAHGUNAAN NARKOTIKA DI MADRASAH ALIYAH DARUL IHSAN TANJUNG SENGKUANG KOTA BATAM. PUAN INDONESIA. https://doi.org/10.37296/jpi.v3i1.44
25. Aronson, J. K., & Smith, A. D. (2002). Drug dependence and abuse. https://doi.org/10.1093/oso/9780192632340.003.0034
26. Arterberry, B. J., Calhoun, B. H., Lee, C. M., & Patrick, M. E. (2022). Young Adult Physical, Social, and Temporal Contexts of Simultaneous Alcohol and Marijuana Use. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.22-00231
27. Ashipala, D. O., Tomas, N., & Joel, M. H. (2020). Smoking. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-7998-2139-7.ch006
28. Atakan, Z. (2008). Cannabis use by people with severe mental illness – is it important?. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.105.002006
29. Athanaselis, S., Papadodima, S., & Spiliopoulou, C. (2012). Smoking Marijuana. Is it Safe for the Heart?. Journal of Forensic Toxicology and Pharmacology. https://doi.org/10.4172/2325-9841.1000e101
30. Athukorala, I., Tilakaratne, W. M., & Jayasinghe, R. D. (2021). Areca Nut Chewing: Initiation, Addiction, and Harmful Effects Emphasizing the Barriers and Importance of Cessation. Journal of Addiction. https://doi.org/10.1155/2021/9967097
31. Atrens, D. M. (2001). Nicotine as an Addictive Substance: A Critical Examination of the Basic Concepts and Empirical Evidence. Journal of Drug Issues. https://doi.org/10.1177/002204260103100202
32. Aynsley, A., Bradley, R., Buchanan, L., Burrows, N., & Bush, M. (2017). Childhood adversity, substance misuse and young people’s mental health..
33. Bachhuber, M. A., Arnsten, J. H., Cunningham, C. O., & Sohler, N. (2018). Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000404
34. Barkus, E. (2008). Personality and cannabis use.
35. Barroso, C. R. D., & Guidoreni, C. G. (2018). Alterações neuropsicológicas causadas pelo uso crônico de cocaína.
36. Barroso, C. R. D., Gomes, L. S., Souza, L. T. D., Silvestre, V. A., & Guidoreni, C. G. (2015). Alterações neuropsicológicas causadas pelo uso crônico da Cocaína. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.644.2.2015
37. Bartzatt, R. (2010). Cannabis Toxicity and Adverse Biological Activity. Research and reviews in biosciences.
38. Bates, J. (2012). Databases & Hot Topics: Addiction and Recovery: Alcoholism.
39. Bates, J. (2012). Databases & Hot Topics: Addiction and Recovery: Compulsive Gambling.
40. Batta, A. (2018). Addiction-How and Type. Global Journal of Addiction & Rehabilitation Medicine. https://doi.org/10.19080/gjarm.2018.05.555656
41. Bautista, M., Mogul, A. S., & Fowler, C. D. (2023). Beyond the label: current evidence and future directions for the interrelationship between electronic cigarettes and mental health. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1134079
42. Beach, S. R. H., Dogan, M. V., Lei, M., Cutrona, C. E., Gerrard, M., Gibbons, F. X., Simons, R. L., Brody, G. H., & Philibert, R. A. (2015). Methylomic Aging as a Window onto the Influence of Lifestyle: Tobacco and Alcohol Use Alter the Rate of Biological Aging. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.13830
43. Beltrán, K., & Cardona, W. (2018). Medical and dental effects of energy drinks consumption. Literature review.. International Journal of Medical and Surgical Sciences. https://doi.org/10.32457/ijmss.2017.013
44. Benito, E. P. (2020). Alteraciones oftalmológicas secundarias a las sustancias de abuso. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
45. Benowitz, N. L., Porchet, H., Sheiner, L. B., & Jacob, P. (1988). Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology & Therapeutics. https://doi.org/10.1038/clpt.1988.107
46. Benoy, R., Ramirez, C., Hitchcock, M., & Reardon, C. L. (2023). Cannabis Use in Adolescent and Young Adult Athletes: A Clinical Review. Sports Health A Multidisciplinary Approach. https://doi.org/10.1177/19417381231208661
47. Berezhnova, I., Antonov, N. S., Sakharova, G. M., Donitova, V. V., Kotov, A. A., & Latif, E. (2014). ELECTRONIC CIGARETTE: ASSESSMENT OF SAFETY AND RISK FOR HEALTH. PULMONOLOGIYA. https://doi.org/10.18093/0869-0189-2014-0-3-122-127
48. Bergé, A. S., & Bustamante, R. M. (2021). Les altres dianes del trastorn per ús d'alcohol: Afectacions sitèmiques derivades del consum excessiu d'alcohol. Mètode: Revista de difusió de la investigació.
49. Bermúdez, J. L., Morales, Ó. A., & León, M. D. L. Á. H. (2017). Factores asociados al inicio del consumo de chimó. Acta Bioclínica.
50. Bersani, F. S., Santacroce, R., Coviello, M., Imperatori, C., Francesconi, M., Vicinanza, R., Minichino, A., & Corazza, O. (2015). Cannabis: a self‐medication drug for weight management? The never ending story. Drug Testing and Analysis. https://doi.org/10.1002/dta.1891
51. Bierut, L. J., & Fang, F. (2025). Time to Act on a Growing Public Health Threat—Evidence of Elevated Mortality in Cannabis Use Disorder. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.57781
52. Billing, L., & Ersche, K. D. (2014). Cocaine’s appetite for fat and the consequences on body weight. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952990.2014.966196
53. Bistuer, M. R. F., Herrero, M. T. V., Alberich, J., & López‐González, Á. A. (2014). Consumo de alcohol y comportamientos violentos. Aspectos médico-legales: una revisión desde la jurisprudencia española.
54. Bistuer, M. R.-F., Herrero, M. T. V., Alberich, J., & López‐González, Á. A. (2014). Consumo de alcohol y comportamientos violentos. Aspectos médico-legales: una revisión desde la jurisprudencia española.(Alcohol and violent behavior. Legal medical aspects: A review from the Spanish case law).
55. Bjelica, B., Aksović, N., Zelenović, M., Pržulj, R., & Radenković, O. (2023). Effect of caffeine on the cardiovascular system and performance: A systematic review. Turkish Journal of Kinesiology. https://doi.org/10.31459/turkjkin.1263307
56. Blacker, C. J. (2020). Clinical Issues to Consider for Clozapine Patients Who Vape: A Case Illustration. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20190025
57. Bolinder, G., & Gilljam, H. (2015). Smokeless Tobacco - Health Hazards or Less Harm?. Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research. https://doi.org/10.1159/000369503
58. Bolton, R. (2017). Drogadependencia… Una mirada desde la Bioética. Inmanencia. Revista del Hospital Interzonal General de Agudos (HIGA) Eva Perón.
59. Bona, C. M. D., Pazotti, A. F., Diniz, C., & Gaio, D. M. (2016). Prevenção de “recaída” em dependentes químicos. Anais do EVINCI - UniBrasil.
60. Bondy, B. (2010). Erhöhtes Suizidrisiko und Antidepressiva. https://doi.org/10.17104/9783406626449-55
61. Boylan, I. (2012). Databases & Hot Topics: Addiction and Recovery: Compulsive Gambling.
62. Bramness, J. (2022). Cannabis Induced Psychosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.45
63. Brandt, A. M. (2008). The cigarette century: the rise, fall, and deadly persistence of the product that defined America. Choice Reviews Online. https://doi.org/10.5860/choice.45-3265
64. Braunstein, M. M. (2022). About the Author. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-207
65. Braunstein, M. M. (2022). Index. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-195
66. Braunstein, M. M. (2022). Mindful Marijuana Smoking. https://doi.org/10.5771/9781538156681
67. Braunstein, M. M. (2022). Notes. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-153
68. Braunstein, M. M. (2022). Part I HEALTH TIPS:10 HEALTH HACKS AND HEALTHFUL SAFEGUARDS. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-1
69. Braunstein, M. M. (2022). Part II HEALTH RISKS: THE DOWNSIDE OF GETTING HIGH. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-139
70. Braunstein, M. M. (2022). Works Cited. Rowman & Littlefield Publishers eBooks. https://doi.org/10.5771/9781538156681-177
71. Brincks, A. M., Perrino, T., Estrada, Y., & Prado, G. (2022). Preventing alcohol use among Hispanic adolescents through a family-based intervention: The role of parent alcohol misuse.. Journal of Family Psychology. https://doi.org/10.1037/fam0001038
72. Britton, J., Arnott, D., McNeill, A., & Hopkinson, N. S. (2016). Nicotine without smoke—putting electronic cigarettes in context. BMJ. https://doi.org/10.1136/bmj.i1745
73. Brnich, N., & Colombres, N. B. (2018). La previa”¿Fenómeno de tolerancia social?. Revista de la Facultad de Ciencias Médicas de Córdoba. https://doi.org/10.31053/1853.0605.v0.n0.21169
74. Broom, S. L., & Yamamoto, B. K. (2007). Role of norepinephrine in substance abuse. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544156.022
75. Brown, H. L., & Graves, C. (2013). Smoking and Marijuana Use in Pregnancy. Clinical Obstetrics & Gynecology. https://doi.org/10.1097/grf.0b013e318282377d
76. Brown, M. R., Anderson, R., Craig, C., & Owen, S. (2023). S2864 Pill-Induced Esophagitis Secondary to Caffeine Pills. The American Journal of Gastroenterology. https://doi.org/10.14309/01.ajg.0000961096.53544.14
77. Brucato, R. (2017). Research Continues to Identify Risks Marijuana Poses to Adolescents, Including the Path to Heroin. Journal of Neurology & Stroke. https://doi.org/10.15406/jnsk.2017.06.00208
78. Bucher, R., & Totugui, M. L. (2012). Influência do sexo e idade em consumidores de drogas em Brasília. Psicologia Teoria e Pesquisa.
79. Budney, A. J., & Lile, J. A. (2009). Moving beyond the cannabis controversy into the world of the cannabinoids. International Review of Psychiatry. https://doi.org/10.1080/09540260902782729
80. Budson, A. E., & Kensinger, E. A. (2023). This is your brain on alcohol, cannabis, and drugs. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197607732.003.0019
81. Buettner‐Schmidt, K., Swanson, K. M., Maack, B., Barnacle, M., Miller, D. R., Orr, M., & Gag, M. H. (2021). E-cigarettes for tobacco cessation. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000798228.69915.64
82. Burke, L. M., & Pyne, D. B. (2007). Bicarbonate Loading to Enhance Training and Competitive Performance. International Journal of Sports Physiology and Performance. https://doi.org/10.1123/ijspp.2.1.93
83. Burrows, T., Carter, A., & Hardman, C. A. (2020). Food Addiction and Eating Addiction. MDPI eBooks. https://doi.org/10.3390/books978-3-03936-359-9
84. Cabral, G. A. L., Curi, T. R. L., Abbas, N. A. B., Lacerda, J. S., Pereira, A. C., & Romualdo, G. S. (2020). A relação entre o uso da cannabis e o despertar de psicoses. Revista Brasileira Multidisciplinar. https://doi.org/10.25061/2527-2675/rebram/2020.v23i1.704
85. Calero, J. D. R., Rey, E. J. A. D., & Rey, M. (1998). El consumo de drogas por adolescentes y jóvenes. Tarbiya: Revista de investigación e innovación educativa.
86. Camacho, M. (2009). Ingested poisons in adults. Nursing Made Incredibly Easy!. https://doi.org/10.1097/01.nme.0000350935.04413.f8
87. Campbell, B., Wilborn, C., Bounty, P. L., Taylor, L., Nelson, M., Greenwood, M., Ziegenfuss, T. N., Lopez, H. L., Hoffman, J. R., Stout, J. R., Schmitz, S., Collins, R., Kalman, D., António, J., & Kreider, R. B. (2013). International Society of Sports Nutrition position stand: energy drinks. Journal of the International Society of Sports Nutrition. https://doi.org/10.1186/1550-2783-10-1
88. Caponnetto, P., Campagna, D., Papale, G., Russo, C., & Polosa, R. (2012). The emerging phenomenon of electronic cigarettes. Expert Review of Respiratory Medicine. https://doi.org/10.1586/ers.11.92
89. Carr, K. A., Daniel, T. O., Lin, H. C., & Epstein, L. H. (2011). Reinforcement Pathology and Obesity. Current Drug Abuse Reviews. https://doi.org/10.2174/1874473711104030190
90. Castiglione, L. M. B. (2016). Diabetes and Depression Cognitive Therapy. Journal of Diabetes Metabolic Disorders & Control. https://doi.org/10.15406/jdmdc.2016.03.00092
91. Castro, L. H. A., Monteiro, G. M., Paula, Y. T. C. D., Ferraz, V. D. S., Mello, F. S. B. O. N. D., Bottini, D. A. M. C., Ferreira, N. T. A., Lino, T. B., Souza, J. V. D., Alencar, G. P. D., Moraes, W. S. D. S., & Moreto, F. V. D. C. (2020). Endocannabinoid system. Deleted Journal. https://doi.org/10.31686/ijier.vol8.iss9.2642
92. Cañarte-Quimis, J. G., Villarreal-Calderón, L. A., & Villigua-Pincay, D. F. (2023). Prevención del consumo de estupefacientes y otras adicciones. MQRInvestigar. https://doi.org/10.56048/mqr20225.7.4.2023.589-609
93. Cermak, T. L. (2020). Understanding and Encouragement. Cambridge University Press eBooks. https://doi.org/10.1017/9781108653428.013
94. Chadi, N., Minato, C., & Stanwick, R. (2020). Cannabis vaping: Understanding the health risks of a rapidly emerging trend. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxaa016
95. Chandy, M., Nishiga, M., Wei, T.-T., Hamburg, N. M., Nadeau, K. C., & Wu, J. C. (2023). Adverse Impact of Cannabis on Human Health. Annual Review of Medicine. https://doi.org/10.1146/annurev-med-052422-020627
96. Chassin, L., Presson, C. C., Sherman, S. J., & Kim, K. (2002). Long-term psychological sequelae of smoking cessation and relapse.. Health Psychology. https://doi.org/10.1037//0278-6133.21.5.438
97. Chellian, R., Wilson, R., Behnood‐Rod, A., & Bruijnzeel, A. W. (2021). Influence of Sex on the Effects of Nicotine and Other Drugs of Abuse on Intracranial Self-Stimulation. Neuromethods. https://doi.org/10.1007/978-1-0716-1748-9_1
98. Chen, C. K., Muhamad, A. S., & Ooi, F. K. (2012). Herbs in exercise and sports. Journal of PHYSIOLOGICAL ANTHROPOLOGY. https://doi.org/10.1186/1880-6805-31-4
99. Chen, G., Rahman, S., & Lutfy, K. (2023). E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs. Advances in Drug and Alcohol Research. https://doi.org/10.3389/adar.2023.11345
100. Cheong, Y. S. (2020). E-cigarette from the point of view of harm reduction. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2020.63.2.105
101. Chesnais, A. (2017). Témoignage d’un parent. Pratiques en santé mentale. https://doi.org/10.3917/psm.172.0043
102. Chhattar, S. (2023). Alcohol and mental health: a comprehensive review. https://doi.org/10.61577/jmhbs.2023.100004
103. Choi, N. G., Choi, B. Y., Marti, C. N., & Baker, D. (2023). Cocaine-involved suspected suicide attempts in individuals age 50 and older reported to United States Poison Centers. Clinical Toxicology. https://doi.org/10.1080/15563650.2023.2244666
104. Choudhury, R. S. (2021). Body Image Concerns, Unhealthy Weight Control Behaviors in Teenagers and the Role of Tobacco Policy. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.4168248
105. Chuah, L. O., Yeap, S. K., Ho, W. Y., Beh, B. K., & Alitheen, N. B. (2012). <i>In Vitro</i>and<i>In Vivo</i>Toxicity of<i>Garcinia</i>or Hydroxycitric Acid: A Review. Evidence-based Complementary and Alternative Medicine. https://doi.org/10.1155/2012/197920
106. Ciampo, L. A. D., & Ciampo, I. R. L. D. (2024). Binge drinking and the risks to adolescent health. Journal of Drug Delivery and Therapeutics. https://doi.org/10.22270/jddt.v14i4.6534
107. Clemente, L. F., Trullén, A. P., & Blázquez, C. M. (2001). Terapias psicológicas en la deshabituación tabáquica. Psiquis: Revista de psiquiatría, psicología médica y psicosomática.
108. Cobb, C. O., Hendricks, P. S., & Eissenberg, T. (2015). Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Medicine. https://doi.org/10.1186/s12916-015-0355-y
109. Coelho, S. G., Hendershot, C. S., Rueda, S., & Wardell, J. D. (2023). Daily associations between cannabis use and alcohol use among people who use cannabis for both medicinal and nonmedicinal reasons: Substitution or complementarity?. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000930
110. Colizzi, M., & Murray, R. (2018). Cannabis and psychosis: what do we know and what should we do?. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.2018.1
111. Collier, D. (2006). THE GENETICS OF CANNABIS INVOLVEMENT IN HUMANS: A GENETIC EPIDEMIOLOGICAL PERSPECTIVE. Addiction. https://doi.org/10.1111/j.1360-0443.2006.01489.x
112. Collins, G., & Rossi, B. V. (2015). The impact of lifestyle modifications, diet, and vitamin supplementation on natural fertility. Fertility Research and Practice. https://doi.org/10.1186/s40738-015-0003-4
113. Compton, M. T., & Broussard, B. (2010). Staying Healthy. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0020
114. Constantin, A.-A., Dumitru, F., & Davila, C. (2023). None. FARMACIA. https://doi.org/10.31925/farmacia.2023.5
115. Copeland, J. (2012). Intervenciones para el trastorno por consumo de cannabis. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
116. Copeland, J., & Alperstein, D. (2016). Cannabis: Use, harms, disorder, and interventions.
117. Cordero-Solís, J. J., Delgado-Gómez, D., & Santillán-Zúñiga, J. (2021). Diagnóstico, Manejo y Seguimiento de los Pacientes Intoxicados con derivados de Cannabis: una revisión narrativa. Revista Hispanoamericana de Ciencias de la Salud. https://doi.org/10.56239/rhcs.2021.74.521
118. Costa, J. L. D., Aguiar, D. M. D., & Souto, Á. D. O. (2019). As consequências sociais, familiares, físicas e psíquicas do dependente de álcool.
119. Cottencin, O., Bence, C., Rolland, B., & Karila, L. (2013). [Somatic consequences of cannabis use].. PubMed.
120. Crocker, C. E., & Tibbo, P. G. (2015). Cannabis and the maturing brain: Role in psychosis development. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.102
121. Croissant, B., Croissant, D., & Mann, K. (2003). Aktuelle Informationen zum Drogenkonsum: Cannabis, Ecstasy, Heroin &amp; Co.. Biologie in unserer Zeit. https://doi.org/10.1002/biuz.200390060
122. Cruz, J. A. V., & Ruiz, B. P. C. (2018). Inmunoterapia y Vacuna en Trastornos por Consumo de Sustancias (Drogas Ilícitas). Revista Médica del Hospital José Carrasco Arteaga. https://doi.org/10.14410/2018.10.1.rb.11
123. Cruz, J. A. V., & Ruiz, B. P. C. (2018). Revisión Bibliográfica: Inmunoterapia y Vacuna en Trastornos por Consumo de Sustancias (Drogas Ilícitas).
124. Curran, C., & Marczinski, C. A. (2017). Taurine, caffeine, and energy drinks: Reviewing the risks to the adolescent brain. Birth Defects Research. https://doi.org/10.1002/bdr2.1177
125. Dadi, S. (2015). Smoking and its Effects on Men?s Sexual Health. Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences.
126. Dahlgren, A., Lidal, I. B., Mosdøl, A., Odgaard‐Jensen, J., Denison, E., & Vist, G. E. (2015). Effects of Information and Other Communication Initiatives on Physical Activity with One or More Other Lifestyle Habits Targeting the General Population [Internet].
127. Daley, D. C., & Douaihy, A. (2006). Understanding Addiction: Alcohol and Drug Abuse or Dependence. https://doi.org/10.1093/oso/9780195311297.003.0002
128. Daley, D. C., & Douaihy, A. (2019). Alcohol and Drug Problems. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0001
129. Daley, D. C., & Douaihy, A. (2019). Medications for Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926670.003.0015
130. Daley, D. C., & Douaihy, A. (2019). Relapse After a Period of Recovery. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0007
131. Damaggio, A. S. (2014). Influence of Time of Day in the Development of Physiological and Behavioral Drug Dependence in Mice.
132. Dammert, L. (2009). Drogas e inseguridad en América Latina: una relación compleja.
133. Das, S., Vk, S., & Vardhan, A. (2016). Electronic cigarettes: Human Friend or Foe. International Journal of Current Research in Medical Sciences. https://doi.org/10.22192/ijcrms.2016.02.12.004
134. Davis, C. N., Ramer, N. E., Squeglia, L. M., Gex, K. S., McRae‐Clark, A. L., McKee, S. A., Roberts, W., Gray, K. M., Baker, N. L., & Tomko, R. L. (2024). Alcohol use and cannabis craving in daily life: Sex differences and associations among young adults. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15461
135. Davis, W., Frye, K., Shah, D., & Cagande, C. C. (2020). Cannabinoid Hyperemesis Syndrome Presenting With Spontaneous Pneumomediastinum. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.19l02509
136. Deepmala, D., Bali, S., Taneja, M., & Choudhary, P. (2019). Effects of drug abuse on oral health. Santosh University Journal of Health Sciences. https://doi.org/10.18231/2455-1732.2018.0016
137. Delás, J., Blanqué, J. M., & González, V. B. (2010). El cannabis y sus peligros. El Ciervo: revista mensual de pensamiento y cultura.
138. Dermody, S. S., & Donny, E. C. (2014). The Predicted Impact of Reducing the Nicotine Content in Cigarettes on Alcohol Use. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntu037
139. Deroche‐Gamonet, V., Belin, D., & Piazza, P. V. (2004). Evidence for Addiction-like Behavior in the Rat. Science. https://doi.org/10.1126/science.1099020
140. Deschamps, C., Debris, M., Vilpoux, C., Naassïla, M., & Pierrefiche, O. (2023). Alcoolisation chez les jeunes. médecine/sciences. https://doi.org/10.1051/medsci/2022191
141. Devi, S., Goyal, S., Rathor, B. S., Kumar, P., & Singla, S. (2023). Updated review on successful control with nicotine replacement therapy for nicotine withdrawal symptoms. International Journal of Science and Research Archive. https://doi.org/10.30574/ijsra.2023.9.1.0352
142. Dhaneria, S. (2023). Drug – Alcohol (Ethyl Alcohol) Interactions. Central India Journal of Medical Research. https://doi.org/10.58999/cijmr.v2i02.115
143. Dia, A. T., Wone, I., Ndiaye, P., Fall, I., & Sarr, Y. F. (2004). Prévalence de l’usage du cannabis en milieu étudiant à Dakar. Cahiers d'études et de recherches francophones / Santé.
144. Dickson, S., & Poulsen, H. (2009). Cannabis. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa420
145. Dix, B., Görner, K., Błeńska, M., Kortas, J., & Żukow, W. (2013). Nordic Walking jako forma aktywności dla ludzi w różnym wieku.
146. Dom, G. (2025). Alcohol and nicotine: quitting both or keep smoking?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.150
147. Domhnaill, S. Ó. (2014). The growth of alcohol addiction. Nursing in general practice.
148. Donny, E. C., Walker, N., Hatsukami, D. K., & Bullen, C. (2016). Reducing the nicotine content of combusted tobacco products sold in New Zealand. Tobacco Control. https://doi.org/10.1136/tobaccocontrol-2016-053186
149. Doulatram, G., Raj, T. D., & Govindaraj, R. (2014). Pregnancy and Substance Abuse. Substance Abuse. https://doi.org/10.1007/978-1-4939-1951-2_35
150. Drewe, J. (2003). Erwünschte und unerwünschte Wirkungen des Cannabiskonsums. Therapeutische Umschau. https://doi.org/10.1024/0040-5930.60.6.313
151. Drummond, C. (2002). Pharmacological approaches to the treatment of excessive drinking and alcohol dependence. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.2.1.119
152. Duarte, G. R., Oliveira, J. V. R. D., & Silva, U. O. D. (2021). TABAGISMO: UM DESAFIO A SE PERFAZER. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. https://doi.org/10.47820/recima21.v2i10.805
153. Dunbar, G. C., Morgan, D. D. V., & Perera, K. M. H. (1988). The Concurrent Use of Alcohol, Cigarettes and Caffeine in British Benzodiazepine Users as Measured by a General Population Survey. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1988.tb02599.x
154. Duncan, A. (2019). NAC for cannabis use disorder and depression. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30376
155. DuPont, R. L. (1998). Addiction: a new paradigm.. PubMed.
156. DuPont, R. L. (2017). “Should Patients With Substance Use Disorders Be Prescribed Benzodiazepines?” No. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000000291
157. Déléaval, M., Burri, H., & Bakelants, E. (2022). Harmless herbs? A case report of acquired long QT syndrome and torsades de pointes in a patient taking herbal supplements. HeartRhythm Case Reports. https://doi.org/10.1016/j.hrcr.2022.03.018
158. Díaz-Jiménez, R., García‐Portilla, M. P., García-Álvarez, L., & Bobes, J. (2012). Impacto del tabaquismo en el trastorno bipolar.
159. D’Angelo, S., & Ascione, A. (2020). Guarana and physical performance: A myth or reality?. https://doi.org/10.14198/jhse.2020.15.proc3.07
160. Echeverri, J. M. M., Botero, A. B., López, J., Uribe, I., Rendón, I., & Gómez, U. (2001). Efectos cardiovasculares de la cocaína. DOAJ (DOAJ: Directory of Open Access Journals).
161. Edwards, G. (2023). The Alcohol Dependence Syndrome: Usefulness of an Idea. Routledge eBooks. https://doi.org/10.4324/9781003460398-11
162. Eidelwein, G. C., Araújo, R. B., & Borba, L. R. (2012). A prática do mindfulness em grupo para dependentes de crack internados.
163. Elam, M. (2012). Pharmaceutical Incursion on Cigarette Smoking at the Birth of the Brain Disease Model of Addiction. Advances in medical sociology. https://doi.org/10.1108/s1057-6290(2012)0000014007
164. Elena-González, A., Cuadros-Tito, P., Esteban-Gutiérrez, G., González, A., & Prudencio, P. (2020). Spice intoxication and hyperglycemia. Anales del Sistema Sanitario de Navarra. https://doi.org/10.23938/assn.0748
165. Elisabet, A., Rosmaida, A., Pratama, A., Jonatan, J., Kristiana, K., Teresia, S., & Yunita, S. (2022). Penyalahgunaan Narkoba Dikalangan Remaja: Bahaya, Penyebab, Dan Pencegahannya. Jurnal Multidisiplin Indonesia. https://doi.org/10.58344/jmi.v1i3.80
166. Enser, B., & Foxcroft, D. (2019). The Harms and Prevention of Drugs and Alcohol on Children. https://doi.org/10.1093/obo/9780199791231-0216
167. Ericsdotter, F. A., & Safi, S. N. (2015). Äta för att leva.
168. Escobar, S. V. A. (2020). Tratamiento nutricional con dieta cetogénica en niños con epilepsia refractaria - revisión narrativa. Revista de Nutrición Clínica y Metabolismo. https://doi.org/10.35454/rncm.v3n2.108
169. Evans, R. (2016). Identifying alcohol or drug abuse in the workplace is beneficial to both employers and employees : advertorial. Occupational Health Southern Africa.
170. Eversman, M. H. (2015). Tobacco Harm Reduction: An Emerging Health Issue for Social Work. Journal of Social Work Practice in the Addictions. https://doi.org/10.1080/1533256x.2015.1091001
171. Fagerström, K. O., & Bridgman, K. M. (2013). Tobacco harm reduction: The need for new products that can compete with cigarettes. Addictive Behaviors. https://doi.org/10.1016/j.addbeh.2013.11.002
172. Fahey, M. C., Little, M. A., Klesges, R. C., Talcott, G. W., Richey, P. A., Mehmet, K., & Krukowski, R. A. (2020). Use of Tobacco for Weight Control across Products among Young Adults in the U.S. Military. Substance Use & Misuse. https://doi.org/10.1080/10826084.2020.1846196
173. Farhadi, H., & hadi, H. (2011). Effect of different dosages caffeine gum ingestion on mid-endurance performance.. Annals of biological research.
174. Faro, D. (2010). Changing the Future by Reshaping the Past: The Influence of Causal Beliefs on Estimates of Time to Onset. SSRN Electronic Journal.
175. Farrell, B., Shamji, S., Monahan, A., & Merkley, V. F. (2013). Reducing polypharmacy in the elderly. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. https://doi.org/10.1177/1715163513499530
176. Farsalinos, K., Voudris, V., & Houezec, J. L. (2014). Risks of Attempting to Regulate Nicotine Flux in Electronic Cigarettes. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntu207
177. Farzaei, M. H., Bayrami, Z., Farzaei, F., Aneva, I., Das, S. K., Patra, J. K., Das, G., & Abdollahi, M. (2020). Poisoning by Medical Plants..
178. Faus, A. F. (2015). Análogos de las benztropinas como agentes terapéuticos para la adicción a la cocaína: Estudios preclínicos en modelos animales de conducta adictiva.
179. Fearby, N., Penman, S., & Thanos, P. K. (2022). Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph19063174
180. Fernández, M. D. F., & Ubago, J. G. (2008). Síndrome de dependencia del alcohol. Jano: Medicina y humanidades.
181. Fernández-Cueto, N., Malebran-Lucero, C., Godoy-Balbontin, N., & Cristi‐Montero, C. (2016). Efecto de la cafeína sobre la baja de peso en adultos con sobrepeso. Journal of Movement & Health. https://doi.org/10.5027/jmh-vol17-issue1(2016)art3
182. Ferreira, J. C. M., & Alves, J. C. B. (2009). ALCOOLISMO: DA DEPENDÊNCIA AOS BENEFÍCIOS DA ATIVIDADE FÍSICA. Fiep Bulletin - online.
183. Fidan, F., Pala, E., Ünlü, M., Sezer, M., & Kara, Z. (2015). Sigara Bırakmayı Etkileyen Faktörler ve Uygulanan Tedavilerin Başarı Oranları. DergiPark (Istanbul University). https://doi.org/10.18229/ktd.62331
184. Finnerty, F., Fitzpatrick, C., Stockwell, S., & Richardson, D. (2019). The changing face of male sexual assault: recreational drug use and multiple assailants. Sexually Transmitted Infections. https://doi.org/10.1136/sextrans-2019-054174
185. Fischer, B., Russell, C., & Tyndall, M. (2015). Cannabis vaping and public health—some comments on relevance and implications. Addiction. https://doi.org/10.1111/add.13064
186. Ford, T. C., Hayley, A. C., Downey, L. A., & Parrott, A. C. (2017). Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications. Current Drug Abuse Reviews. https://doi.org/10.2174/1874473710666170712113042
187. Forti, M. D., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O’Connor, J., Russo, M., Stilo, S. A., Marques, T. R., Mondelli, V., Dazzan, P., Pariante, C. M., David, A. S., Gaughran, F., Atakan, Z., Iyegbe, C., ... Murray, R. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(14)00117-5
188. Franjić, S. (2020). Alcohol Addiction can have many Health Consequences.
189. Freels, T. G., Westbrook, S. R., Zamberletti, E., Kuyat, J. R., Wright, H. R., Malena, A. N., Melville, M. W., Brown, A. M., Glodosky, N. C., Ginder, D. E., Klappenbach, C. M., Delevich, K., Rubino, T., & McLaughlin, R. J. (2024). Sex Differences in Response-Contingent Cannabis Vapor Administration During Adolescence Mediate Enduring Effects on Behavioral Flexibility and Prefrontal Microglia Activation in Rats. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2023.0014
190. French, L., Gray, C., Leonard, G., Perron, M., Pike, G. B., Richer, L., Séguin, J. R., Veillette, S., Evans, J., Artiges, É., Banaschewski, T., Bokde, A. L., Bromberg, U., Bruehl, R., Büchel, C., Cattrell, A., Conrod, P., Flor, H., Frouin, V., ... Paus, T. (2015). Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2015.1131
191. Frye, C. C. J., Rung, J. M., Nall, R. W., Galizio, A., Haynes, J. M., & Odum, A. L. (2018). Continuous nicotine exposure does not affect resurgence of alcohol seeking in rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0202230
192. Gaiha, S. M., & Halpern‐Felsher, B. (2020). Public Health Considerations for Adolescent Initiation of Electronic Cigarettes. PEDIATRICS. https://doi.org/10.1542/peds.2019-2056e
193. Galicia, D. X. D. S. P. (2020). Tabaco y Cannabis.
194. Gang‐, C. (2012). 酒精戒断症与依赖症药物治疗研究进展. 中国综合临床. https://doi.org/10.3760/cma.j.issn.1008-6315.2012.10.035
195. García, A. M. (2016). Efectos a largo plazo de la exposición al alcohol y a la cocaína durante la adolescencia en modelos animales: factores de riesgo y posibles tratamientos en la adicción a la cocaína.
196. García–Rodríguez, O., Pericot‐Valverde, I., Gutiérrez‐Maldonado, J., & Ferrer‐García, M. (2009). La Realidad Virtual como estrategia para la mejora de los tratamientos del tabaquismo.
197. Gartner, C. (2015). Mull it over: cannabis vaporizers and harm reduction. Addiction. https://doi.org/10.1111/add.13139
198. Gawin, F. H. (1991). Cocaine Addiction: Psychology and Neurophysiology. Science. https://doi.org/10.1126/science.2011738
199. George, T. P., & Vaccarino, F. J. (2015). The effects of cannabis use during adolescence..
200. Gerada, C., & Ashworth, M. (1997). ABC of mental health: Addiction and dependence II: Alcohol. BMJ. https://doi.org/10.1136/bmj.315.7104.358
201. Gerada, C., & Ashworth, M. T. (1997). ABC of mental health: Addiction and dependence I: Illicit drugs. BMJ. https://doi.org/10.1136/bmj.315.7103.297
202. Gil, F. G., Andrade, A. G. D., & Castaldelli-Maia, J. M. (2016). Discussing prevalence, impacts, and treatment of substance use disorders in athletes. International Review of Psychiatry. https://doi.org/10.1080/09540261.2016.1212821
203. Gitlow, S. (2014). SY14-3 * MARIJUANA - THE STATE OF THE UNITED STATES. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agu052.60
204. Glover, M., Breier, B. H., & Bauld, L. (2016). Could Vaping be a New Weapon in the Battle of the Bulge?. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntw278
205. Goldstein, R. Z. (2008). Self-Control in Cocaine Addiction (440th Brookhaven Lecture).
206. Gonidakis, F. (2015). Compulsive Bowel Emptying and Rectal Prolapse in Eating Disorders. Presentation of Two Cases. Archives of Depression and Anxiety. https://doi.org/10.17352/2455-5460.000005
207. Goniewicz, M. Ł., & Delijewski, M. (2012). Nicotine vaccines to treat tobacco dependence. Human Vaccines & Immunotherapeutics. https://doi.org/10.4161/hv.22060
208. Goodpaster, K. (2025). Cannabis, Weight, and Weight-Related Behaviors. Current Obesity Reports. https://doi.org/10.1007/s13679-025-00633-z
209. Gorini, G. (2015). [Tobacco control experience in the debate on marijuana legalisation].. PubMed.
210. Gossop, M. (2013). Alcohol, still the forgotten drug. Addiction. https://doi.org/10.1111/add.12045
211. Goswami, H., & Mathew, T. (2024). Forensic Analysis of Salivary Nicotine by Calix[4]Arene Customized Gold Nanoparticles in Water and Soil. International Journal of Membrane Science and Technology. https://doi.org/10.15379/ijmst.v10i5.3408
212. Graham, M. R., Davies, B., Grace, F., Kicman, A. T., & Baker, J. S. (2008). Patterns of Use and Detection of Doping.
213. Graham, P. (2004). Alcohol, drugs: having fun or playing with fire?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526247.003.0008
214. Grant, C. N., & Bélanger, R. E. (2017). Cannabis and Canada’s children and youth. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx017
215. Grant, C. N., & Bélanger, R. E. (2017). Le cannabis et les enfants et adolescents canadiens. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx018
216. Graziani, P. (2016). L'alcolismo giovanile e le terapie comportamentali e cognitive. PSICOBIETTIVO. https://doi.org/10.3280/psob2015-003003
217. Green, A. I., Evins, A. E., Kane, J. M., & Murray, R. (2013). Does Using Marijuana Increase the Risk for Developing Schizophrenia?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.12012tx2c
218. Grenier, E., Ryan, M., Mithani, Z., & Junquera, P. (2013). Cannabis Use and Psychosis. Addictive Disorders & Their Treatment. https://doi.org/10.1097/adt.0b013e3182624271
219. Griffith, C. (2018). Genetics, Inheritability Factors and Addiction. Clinical & Medical Biochemistry Open Access. https://doi.org/10.4172/2471-2663.1000143
220. Grimaldi, P. (2021). Cannabis and male reproduction: Impact on offspring via sperm epigenome. Biocell. https://doi.org/10.32604/biocell.2022.017588
221. Groner, J. A., Walley, S. C., Etzel, R. A., Wilson, K. M., Farber, H. J., Balk, S. J., & Moore, J. E. (2015). Public Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke. PEDIATRICS. https://doi.org/10.1542/peds.2015-3109
222. Guillain, C., Jacques, J.-P., Zombek, S., & Duez, P. (2004). Cannabis: Les scientifiques sont d’accord plus qu’ils ne l’admettent. Journal de pharmacie de Belgique.
223. Gupta, C., & Prakash, D. (2020). Nutraceutical Intervention for Treatment of Alcoholism and Drinking Problems. Apple Academic Press eBooks. https://doi.org/10.1201/9780367821517-15
224. Gupta, K., & Khurana, S. (2014). The painkillers – what we must know!. Biotech Today. https://doi.org/10.5958/2322-0996.2014.00026.x
225. Gérard, P., Perriot, J., & Underner, M. (2021). Chronic Co-Use of Tobacco and Cannabis: A State of Knowledge. Archives of Addiction and Rehabilitation. https://doi.org/10.36959/843/428
226. Gómez, C. P., & Barrera, A. B. (2008). Daños relacionados con el consumo de cocaína: la punta del iceberg es lo que vemos. Adicciones. https://doi.org/10.20882/adicciones.284
227. Gómez, L. R. (2009). Ingesta de alcohol entre indígenas de Chiapas. Estudio de cuatro casos. LiminaR Estudios Sociales y Humanísticos. https://doi.org/10.29043/liminar.v7i1.320
228. Hadis, M. A., Palin, W. M., Perryer, D. G., & Burke, F. T. (2017). Advice for festive drinkers. Dental Update. https://doi.org/10.12968/denu.2017.44.11.1076
229. Hadley, M. N., & Reddy, S. V. (1997). Smoking and the Human Vertebral Column: A Review of the Impact of Cigarette Use on Vertebral Bone Metabolism and Spinal Fusion. Neurosurgery. https://doi.org/10.1097/00006123-199707000-00025
230. Hall, W., & Martin, B. R. (1997). The health effects of cannabis: Key issues of policy relevance. Bulletin on narcotics.
231. Hampl, J. S., & Betts, N. M. (2009). Cigarette Use During Adolescence: Effects on Nutritional Status. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.1999.tb06945.x
232. Hanson, G. (2011). Spice: What it is, What it isn't, and What should we do about it. Planta Medica. https://doi.org/10.1055/s-0031-1273529
233. Harding, W. M. (2020). Informal Social Controls and the Liberalization of Drug Laws and Policies. CRC Press eBooks. https://doi.org/10.4324/9781003078364-15
234. Hariantika, R. D., Sukinta, & Baskoro, B. D. (2016). PROSES PEMUSNAHAN BARANG BUKTI NARKOBA SEBELUM PUTUSAN HAKIM DI WILAYAH HUKUM POLRETBES SEMARANG. Diponegoro Law Journal.
235. Harish, D., Sharma, B., & Chavali, K. (2008). Substance abuse and its medico-legal implications: An overview. Journal of Forensic Medicine.
236. Harlow, A. F., Vogel, E. A., Tackett, A. P., Cho, J., Han, D., Wong, M., Cockburn, M., Sussman, S., Unger, J. B., Leventhal, A. M., & Barrington‐Trimis, J. L. (2023). Adolescent Use of Flavored Non-Tobacco Oral Nicotine Products. American Academy of Pediatrics eBooks. https://doi.org/10.1542/9781610027052-part01-adolescent
237. Hartmann‐Boyce, J., & Aveyard, P. (2016). Drugs for smoking cessation. BMJ. https://doi.org/10.1136/bmj.i571
238. Hasanović, M., Zigic, N., Pajević, I., & Jakovljević, M. (2022). Possible Consequences of Cannabis Legalization - What Do Research Show?. PubMed.
239. Hazzard, A. A., McCrorey, M., Salman, T., Johnson, D. E., Luo, Z., Fu, X., Keegan, A. P., Benitez, A., Fitting, S., & Jiang, W. (2024). Cannabis use, oral dysbiosis, and neurological disorders. NeuroImmune Pharmacology and Therapeutics. https://doi.org/10.1515/nipt-2024-0012
240. Hałasiński, P., Musielak, M., & Piotrowski, I. (2022). Napoje energetyczne wśród młodzieży — tendencja i mechanizmy farmakologiczne niekorzystnego wpływu na układ sercowo-naczyniowy. Przegląd literatury. Folia Cardiologica. https://doi.org/10.5603/fc.a2022.0013
241. Health, A. O. S. A. (2020). Tobacco control in the United States: Failure to protect the right to health. Tobacco Prevention & Cessation. https://doi.org/10.18332/tpc/122543
242. Hedaoo, S. A., & Mahapatra, D. K. (2020). Exploring the Hidden Ethnobotanical Treasures for Treating or Managing Chronic Alcoholism. Apple Academic Press eBooks. https://doi.org/10.1201/9781003057932-2
243. Henry, S. L., Jamner, L. D., & Whalen, C. K. (2012). I (should) Need a Cigarette: Adolescent Social Anxiety and Cigarette Smoking. Annals of Behavioral Medicine. https://doi.org/10.1007/s12160-011-9340-7
244. Heraganahally, S. S., Monsi, E., Gadil, E., Maze, D., & Lynch, S. (2023). Case Report: Catastrophic Effects of Using Cannabis Via Bucket Bong in Top End Northern Territory of Australia. American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0393
245. Herdener, M., Esposito, F., Hänggi, J., Preller, K. H., Stämpfli, P., Kirschner, M., Seifritz, E., & Quednow, B. (2015). Structural and functional brain changes in chronic cocaine users. Suchttherapie. https://doi.org/10.1055/s-0035-1557702
246. Hidalgo, L. F. (2015). El tabaco como factor de riesgo en el cáncer de pulmón. Nuberos científica.
247. Hoch, E., & Preuss, U. W. (2019). Cannabis, Cannabinoide und Cannabiskonsumstörungen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-1008-7427
248. Hoffmann, B. (2009). Original Contribution SOCIO-CULTURAL TRANSFORMATION AND DRUG DEPENDENCE IN YOUTH.
249. Holdridge, S. L., & Holdridge, C. D. (2014). Cannabis and mental health problems. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738014558339
250. Hollister, L. E. (1998). Health aspects of cannabis: revisited. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145798001060
251. Hong, S. W., Teesdale‐Spittle, P., Page, R., Ellenbroek, B., & Truman, P. (2022). Biologically Active Compounds Present in Tobacco Smoke: Potential Interactions Between Smoking and Mental Health. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.885489
252. Hope, B. T. (1999). Cocaine and a Mechanism for Long-Term Changes in Gene Expression. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-710-9_21
253. Hossain, A., Hossain, Q. Z., Azad-uz-zaman, Q., & Rahman, F. (2015). Factors Influencing Teenager to Initiate Smoking in South-west Bangladesh. Universal Journal of Public Health. https://doi.org/10.13189/ujph.2015.030603
254. Hua, J. P., Cano, M., Batki, S. L., & Pennington, D. (2023). Impact of Alcohol Use, Traumatic Stress, and Cigarette Smoking on Cognitive Functioning in Veterans With Co-occurring Alcohol Use Disorder and Posttraumatic Stress Disorder.. PubMed. https://doi.org/10.1093/milmed/usac282
255. Hubbard, J. P., Franco, S. E., & Onaivi, E. S. (1999). Marijuana: medical implications.. PubMed.
256. Hughes, J. (1991). Symptoms of Tobacco Withdrawal. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1991.01810250054007
257. Hughes, J. R. (1988). Dependence potential and abuse liability of nicotine replacement therapies.. PubMed.
258. Hurd, Y. L., Ferland, J. N., Nomura, Y., Hulvershorn, L. A., Gray, K. M., & Thurstone, C. (2023). Cannabis Use and the Developing Brain: Highs and Lows. Frontiers for Young Minds. https://doi.org/10.3389/frym.2023.898445
259. Hyatt, B., & Bensky, K. P. (1999). Illicit drugs and anesthesia.. PubMed.
260. Ide, S., & Ikeda, K. (2020). Animal models in addiction research. Proceedings for Annual Meeting of The Japanese Pharmacological Society. https://doi.org/10.1254/jpssuppl.93.0_1-s04-2
261. Ifdil, I., Fadli, R. P., Rangka, I. B., Suranata, K., & Situmorang, D. D. B. (2021). Anxiety, Depression, Psychological Symptoms, Negative Effects, and Other Symptoms of Nicotine Withdrawal. Addictive Disorders & Their Treatment. https://doi.org/10.1097/adt.0000000000000288
262. Ifland, J., & Roselle, R. S. (2017). DSM 5 SUD Criterion 9 Use in Spite of Consequences. https://doi.org/10.1201/9781315119922-21
263. Ikar, M., & Sable, S. (2023). Tea, coffee and green tea consumption and mental health outcomes: A systematic review and meta-analysis of observational and intervention studies on stress and related conditions. Journal of Pharmacognosy and Phytochemistry. https://doi.org/10.22271/phyto.2023.v12.i2c.14660
264. Intyre, M. S. M. (2014). Factors Related to Simultaneous Cocaine and Alcohol Use for Clients in Treatment. Journal of Alcoholism and Drug Dependence. https://doi.org/10.4172/2329-6488.1000193
265. Islam, S. U. (2015). Management of Depression and Uses of Natural Medicine. General Medicine Open Access. https://doi.org/10.4172/2327-5146.1000205
266. Isyaka, S. M., Ibrahim, S., & Abdullahi, A. M. (2025). Review on Selected Toxic, Narcotics and Psychoactive Plants Used in Nigeria. https://doi.org/10.64290/bima.v9i1a.897
267. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Alcohol. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0649
268. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Recreational Psychoactive Drugs. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0533
269. Ivsins, A., Bonn, M., McNeil, R., Boyd, J., & Kerr, T. (2024). A qualitative study on perceptions and experiences of overdose among people who smoke drugs in Vancouver, British Columbia. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2024.111275
270. Jabbar, S. B., & Hanly, M. G. (2013). Fatal Caffeine Overdose. American Journal of Forensic Medicine & Pathology. https://doi.org/10.1097/paf.0000000000000058
271. Jayaswal, A., & Singh, D. P. (2025). Substance Abuse and Its Addiction Among Young Adults. INTERNATIONAL JOURNAL OF PROFESSIONAL STUDIES. https://doi.org/10.37648/ijps.v20i01.012
272. Jerez, A. F. H., Gil, F., & Martínez, A. P. (1999). Nuevas perspectivas en el análisis de drogas de abuso para el año 2000. Revista electrónica de ciencia penal y criminología.
273. Jerônimo, T. K. D. S., Filho, R. A. M., Oliveira, P. A. P. D., Agripino, G. G., & Marinho, S. A. (2025). Impactos do consumo de bebidas energéticas na saúde. Contribuciones a las Ciencias Sociales. https://doi.org/10.55905/revconv.18n.9-203
274. Jetty, R., Banerji, A., Berry, M., Fraser-Roberts, L., Goldade, R., Irvine, J. C., Menard, K., Pelletier, V., Wong, S., Bell, S., Morningstar, M., Monkman, L., Ryan, A. C., Vides, E., Wiebe, P. K., & Mazerolle, M. (2017). Tobacco use and misuse among Indigenous children and youth in Canada. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxx124
275. Johnson, K. (2022). The Characteristics, Risks, Effects, and Pathophysiology of Eating Disorders -A Review of Anorexia Nervosa and Bulimia Nervosa. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2022.45427
276. Johnson‐Ferguson, L., & Forti, M. D. (2021). From heavy cannabis use to psychosis: is it time to take action?. Irish Journal of Psychological Medicine. https://doi.org/10.1017/ipm.2021.33
277. Johnstone, S., Sorkhou, M., Zhang, M., Dermody, S. S., Rabin, R. A., & George, T. P. (2024). Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2023.2292010
278. Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine. https://doi.org/10.1097/mcp.0000000000000026
279. Joyce, K. M., Thompson, K., Tibbo, P., Good, K. P., O'Leary, E., Perrot, T. S., Hudson, A. L., & Stewart, S. H. (2021). The Impact of Depressed Mood and Coping Motives in those with Pre-Menstrual Dysphoric Disorder on Cannabis Use Quantity across the Menstrual Cycle. https://doi.org/10.26828/cannabis.2021.01.000.40
280. Jun, Y. J., Kim, H., & Park, S. (2014). Suicidal Death by Nicotine Poisoning. Korean Journal of Legal Medicine. https://doi.org/10.7580/kjlm.2014.38.4.167
281. K.V, V., Kumar, S., Navale, S., & B.M, S. (2023). “DHUMAPANA: AYURVEDIC HERBAL SMOKE THERAPY”. International Ayurvedic Medical Journal. https://doi.org/10.46607/iamj3311112023
282. Kaarne, T., & Aalto, M. (2009). Alcohol and working life. Duodecim lääketieteellinen aikakauskirja.
283. Kadir, S. A., Doni, C., Rasyid, M. T., Astuti, N. K., Arif, N., & Ashar, A. N. P. C. (2024). The Influence of Drug Abuse on the Young Generation. Formosa Journal of Applied Sciences. https://doi.org/10.55927/fjas.v3i2.7783
284. Kaelin, R. M. (2009). ["Smoke smarts": how to help patients to stop smoking?].. PubMed.
285. Kalant, H. (1989). Addiction. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6768-8_1
286. Kalant, H. (1989). Addiction. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6778-7_26
287. Kalra, S., Bhogal, S., Kumar, K., Ragupathi, N. K. D., & Kaushal, R. K. (2021). The Negative Impact of Food Neophobia on the People of Chandigarh Tri-City, India. SPAST Abstracts.
288. Kamrul, R., Bunka, D., CRAWLEY, A. E., Schuster, B., & LeBras, M. (2019). Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.. PubMed.
289. Karaaziz, M., & Keskindağ, B. (2016). A Popular Psychoactive Substance Among Youth; Synthetic Cannabinoid (bonsai): A Review. Journal of Clinical Psychiatry. https://doi.org/10.5505/kpd.2016.03522
290. Karege, G., Dominati, S., & Guerreiro, I. (2023). Conséquences respiratoires de l’inhalation de cannabis. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2023.19.850.2160
291. Kaskie, B., Martinos, F., Bhagianadh, D., Arora, K., Moore, A., Nguyen, A. L., & Bobitt, J. (2025). Taking Care of Themselves: Cannabis Use Among Informal Care Partners of Older Adults. Cannabis and Cannabinoid Research. https://doi.org/10.1177/25785125251380073
292. Kataveni, S., Gourishetty, R. P., Mundada, S. M., Avvaru, M. P., Kollipara, V. S., & Gottimukkala, S. P. (2025). Clenbuterol Abuse in Bodybuilding and Athletics: Unsupervised Use, Psychological Motivations, and Health Consequences. Cureus. https://doi.org/10.7759/cureus.84904
293. Kattekola, P. K. (2020). Alochol Addiction and its Treatment. Journal of Drug Abuse.
294. Kaur, J., Rossi, A., Adams, S. K., Varowal, M. S., Jain, L., Raza, M., & Sarfraz, Z. (2025). Novel Treatments for Adolescent Vaping Cessation: Are We There Yet?. Journal of Community Hospital Internal Medicine Perspectives. https://doi.org/10.55729/2000-9666.1526
295. Kavanagh, D. J., Young, R. M., White, A., Saunders, J. B., Shockley, N., Wallis, J., & Clair, A. (2002). Start Over and Survive: A Brief Intervention for Substance Misuse in Early Psychosis. https://doi.org/10.1002/9780470713846.ch14
296. Kelley, L. (2021). Marijuana in Pregnancy. Neonatology Today. https://doi.org/10.51362/neonatology.today/202151653839
297. Kenadi, S. (2021). A NOTE on DRUG and ADDICTION EFFECTS. Journal of Alcoholism and Drug Dependence.
298. Kenna, G. A., Agath, K., & Swift, R. M. (2008). Pharmacotherapy of alcohol misuse, dependence and withdrawal. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544392.016
299. Kennedy, C. C. (2016). Critical Care Medicine. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190464868.003.0070
300. Ketkowit, K., Thavondunstid, P., Kompor, P., Champhosri, W., Skulsuksai, G., Klannamtip, P., Muphaiboon, P., & Junraksa, P. (1989). Narcotic Problem in KhonKaen Correctional Institution For Drug-Addicted Offenders.. ศรีนครินทร์เวชสาร (Srinagarind Medical Journal).
301. Khan, K. S. A., Yasmeen, K., & Imam, M. A. (2013). Influence of Alcohol Addicted Parents in the Development of Alcoholic Behaviour of their Children. Indian Journal of Health and Wellbeing.
302. Khas, S. S. M., & Ghassemi, N. B. (2025). Effects of caffeine on depression in athletes: A narrative review. Journal of Sports and Rehabilitation Sciences.. https://doi.org/10.32598/jsrs.2412.1027
303. Kiianmaa, K., Hyytiä, P., & Sinclair, J. D. (2003). Development of an Animal Model of Ethanol Abuse: Genetic Approach. Humana Press eBooks. https://doi.org/10.1385/0-89603-217-5:29
304. Kim, D. G., Powers, S., & Gitto, L. (2024). Death Due to Caffeine and Methamphetamine Toxicity: A Case Report. Cureus. https://doi.org/10.7759/cureus.66634
305. Kim, H. (2019). Empirical Reasons and Scientific Evidence that do not Support Controlled Drinking but Alcohol Abstinence. Korean Academy of Addiction Psychiatry. https://doi.org/10.37122/kaap.2019.23.2.51
306. Kinney, J. M. (2009). Influence of Altered Body Weight on Energy Expenditure. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.1995.tb05484.x
307. Klein, A. (2018). Poly and Tricky Dick: The drug war origins of the term “polydrug use”. Nordic Studies on Alcohol and Drugs. https://doi.org/10.1177/1455072518786666
308. Klein, M. D., Sokol, N., & Stroud, L. R. (2019). Electronic Cigarettes: Common Questions and Answers.. PubMed.
309. Knapp, M., & McCabe, D. (2022). Substance Use Risk Reduction. CRC Press eBooks. https://doi.org/10.1201/9781003178330-8
310. Knopf, A. (2016). Nonwhite youth have more academic problems on alcohol and marijuana than white youth. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30145
311. Kondratavičiūtė, G., Banionis, D., Laima, S., Chmieliauskas, S., Vasiljevaitė, D., Petreikis, P., & Badaras, R. (2025). Sudden Unexpected Death and Alcohol Addiction: Case Report on Disulfiram Use. Acta medica Lituanica. https://doi.org/10.15388/amed.2025.32.1.5
312. Konopka, L. M. (2014). Marijuana use: neuroscience perspective. Croatian Medical Journal. https://doi.org/10.3325/cmj.2014.55.281
313. Koplan, K., David, S. P., & Rigotti, N. A. (2008). Smoking cessation. BMJ. https://doi.org/10.1136/bmj.39248.531748.47
314. Korenis, P. (2016). Synthetic Cannabis: What Doctors Need to Know. MOJ Addiction Medicine & Therapy. https://doi.org/10.15406/mojamt.2016.02.00017
315. Kornetsky, C., Moolten, M. S., & Bain, G. T. (1991). Ethanol and Rewarding Brain Stimulation. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4757-1305-3_9
316. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.1992.tb00029.x
317. Kosten, T. R. (1992). Can Cocaine Craving Be a Medication Development Outcome?: Drug Craving and Relapse in Opioid and Cocaine Dependence. American Journal on Addictions. https://doi.org/10.3109/10550499209004025
318. Kotewar, S. S., Pakhale, A., Tiwari, R., Reche, A., & Singi, S. R. (2023). Electronic Nicotine Delivery System: End to Smoking or Just a New Fancy Cigarette. Cureus. https://doi.org/10.7759/cureus.43425
319. Kothadia, J. P., Dash, A., Verma, R., Kreitman, K., Snell, P. D., & Ismail, M. K. (2022). Adult Intussusception in Chronic Marijuana Users. Gastroenterology Research. https://doi.org/10.14740/gr1554
320. Kozer, E., & Koren, G. (2001). Effects of prenatal exposure to marijuana.. PubMed.
321. Kreider, R. B. (2018). Current perspectives of caffeinated energy drinks on exercise performance and safety assessment. Nutrition and Dietary Supplements. https://doi.org/10.2147/nds.s143147
322. Krishnan, S., Hizam, S. M., Norefendie, F., Hashim, D. S., & Mazlan, N. (2017). Medical Cannabis: In Medicine Perspective for Human.
323. Králíková, E., & Ježek, M. (2012). [Electronic cigarette].. PubMed.
324. Kukreja, S. (2020). LEVELS OF VITAMIN C IN CHAIN SMOKERS. International Journal of Medical and Biomedical Studies. https://doi.org/10.32553/ijmbs.v4i7.1436
325. Kulkarni, K. S. (2001). A Study of PartySharp in Prevention of Hangover and in Elimination of Acetaldehyde.
326. Kumar, J., Kushwaha, S., Tomar, A., Ramanna, T., Prabhakar, I., & Chaudhry, M. (2015). Tobacco and Oral Health . The Journal of Dentists. https://doi.org/10.12974/2311-8695.2015.03.01.2
327. Kumar, S., Kumari, A., & Murarka, S. (2009). Lifestyle factors in deteriorating male reproductive health.. Indian Journal of Experimental Biology.
328. Kuttivila, M. S. T., & saxena, V. L. (2021). A STUDY TO EVALUATE THE EFFECTIVENESS OF GROUP THERAPY ON STRESS AMONG THE ALCOHOLICS IN SELECTED DEADDICTION CENTRES IN KERALA. THE GENESIS. https://doi.org/10.47211/tg.2021.v08i04.013
329. Källström, F. (2017). The Negative Consequences of Alcohol Intoxication andits Relation to Impulsivity and Gender Differences.
330. Lachance, C. C., & Frey, N. (2020). Non-Pharmacological and Pharmacological Interventions for Smoking Cessation Programs in Youth: A Review of Clinical Effectiveness and Guidelines [Internet].
331. Laerte, D. S. D., Maria, R. U. C., & Lucia, G. N. (2018). CIGARRILLO ELECTRÓNICO. ¿UN PRODUCTO SEGURO?. morfovirtual2018.
332. Lameiras, B. E. T. (2020). Síndrome Amotivacional nos Consumidores de Canábis.
333. Lampkin, C. (2020). Healthy Living During Extraordinary Times: Exercise and Stress. https://doi.org/10.26419/res.00386.003
334. Lamy, S., Delavene, H., & Thibaut, F. (2014). [Licit and illicit substance use during pregnancy].. PubMed.
335. Lape, E. C., Paladino, M. B., Powers, J. M., LaRowe, L. R., & Ditre, J. W. (2024). Awareness of the potential consequences of alcohol consumption in the context of chronic pain and prescription opioid use. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2024.2375515
336. Larsson, M. (2022). [Nicotine, alcohol and opioids - three interacting substances].. PubMed.
337. Latt, N., Conigrave, K. M., Saunders, J. B., Marshall, E. J., & Nutt, D. (2009). Chapter 7 Cannabis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199539338.003.0007
338. Lavanya, C. (2018). A Descriptive Study to Assess the Knowledge Regarding the Effects of Alcoholism among the Men in Community, Kurumanapalam, Visakhapatnam, Andhra Pradesh.. International Journal for Advance Research and Development.
339. Lawn, W., Curran, H. V., & Freeman, T. P. (2023). Cannabis and Addiction. Cambridge University Press eBooks. https://doi.org/10.1017/9781108943246.029
340. Leduc, C., & Quoix, É. (2015). Is there a role for e-cigarettes in smoking cessation?. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/1753465815621233
341. Lee, C. M. (2015). Pharmacotherapy to Quit: Beyond the Guidelines. Journal of the Korean Society for Research on Nicotine and Tobacco. https://doi.org/10.25055/jksrnt.2015.6.1.10
342. Lee, C., Vo, T. T. T., Wee, Y., Chiang, Y., Chi, M., Chen, M., Hsu, L., Fang, M.-L., Lee, K., Guo, S., Cheng, J. H.-C., & Lee, I. (2021). The Adverse Impact of Incense Smoke on Human Health: From Mechanisms to Implications. Journal of Inflammation Research. https://doi.org/10.2147/jir.s332771
343. Leelavathi, L. (2021). Passive Smoking - An Overview. International Journal of Dentistry and Oral Science. https://doi.org/10.19070/2377-8075-21000694
344. Lefebvre, A. D., Sears, R. W., & Ossege, J. M. (2019). Encouraging Empowerment Among Group Members. Routledge eBooks. https://doi.org/10.4324/9781315145914-9
345. Leonard, J. S., & Pathak, M. K. (2020). Legal Use of Marijuana: Will Scientific Evidence Overwhelm Self-Perceived High Feeling?. Science Insights. https://doi.org/10.15354/si.20.re051
346. Leslie, E., Smirnov, A., Najman, J. M., & Scott, J. (2016). Alcohol use and motivations for drinking among types of young adult illicit stimulant users. https://doi.org/10.52922/ti150606
347. Leung, S. (2002). Facts and Myths of Common Drugs Abused in Hong Kong. Hong Kong journal of psychiatry.
348. Leventhal, A. M., Goldenson, N. I., Cho, J., Kirkpatrick, M. G., McConnell, R., Stone, M. D., Pang, R. D., Audrain‐McGovern, J., & Barrington‐Trimis, J. L. (2019). Flavored E-cigarette Use and Progression of Vaping in Adolescents. PEDIATRICS. https://doi.org/10.1542/peds.2019-0789
349. Li, C., & Ma, X. (2023). Effects and Withdrawal of Drug Addiction. Journal of Education Humanities and Social Sciences. https://doi.org/10.54097/ehss.v8i.4502
350. Li, T.-K., Lumeng, L., McBride, W. J., Murphy, J. M., Froehlich, J. C., & Morzorati, S. L. (1988). Pharmacology of Alcohol Preference in Rodents. Advances in Alcohol & Substance Abuse. https://doi.org/10.1300/j251v07n03_11
351. Lima, I. M. B. D. (2016). Níveis de resiliência e qualidade de vida em mulheres que fazem consumo excessivo de álcool em João Pessoa-PB.
352. Lin, A., O’Connor, M. J., Behnam‐Hanona, R., Hatef, C., & Milanaik, R. (2022). Edible marijuana products and potential risks for pediatric populations. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0000000000001132
353. Lingford‐Hughes, A., & Clementi, N. (2008). Addiction and substance misuse. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.004
354. Livne, O., Budney, A. J., Borodovsky, J. T., Shmulewitz, D., Walsh, C., Struble, C. A., Habib, M. I., Aharonovich, E., & Hasin, D. S. (2024). Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2024.2309340
355. Lopes, P. M. A., Dias, A. P. S., Zanini, É. R. S., Camboin, F. F., Seimetz, G., & Ferreira, L. (2012). Smoking Sue e os Efeitos do Tabagismo. 10º Congresso Internacional da Rede Unida.
356. Lorenzo, M., & Beno, S. (2023). Evolving threat of pediatric ingestions: a discussion of cannabis and button batteries and their implications for children. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0000000000001238
357. Losekann, A. B., & Pimentel, F. H. D. O. (2016). USO DA AURICULOTERAPIA PARA A REDUÇÃO DO TABAGISMO. Anais do Salão de Ensino e de Extensão.
358. Lowe, D. J. E., Sorkhou, M., & George, T. P. (2024). Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2023.2299922
359. López, J. M. (2021). Introduction: Willpower hijacked. The science of addictions. Mètode Revista de difusió de la investigació. https://doi.org/10.7203/metode.12.21075
360. López‐Cruz, L., Pardo, M., Dosda, A., & Correa, M. L. (2009). Efecto ansiogénico y supresión motora inducidos por dosis altas de cafeína: Estudio en modelos animales. Fòrum de Recerca.
361. Macdonald, D. I. (1988). Substance Abuse. Pediatrics in Review. https://doi.org/10.1542/pir.10.3.89
362. Madukwe, A. U. (2013). Motivational Interview; Evidence Based Strategy In The Treatment of Alcohol And Drug Addiction. IFE PsychologIA.
363. Mahato, T. K., & Singh, V. (2021). Present scenario of policies &amp; hazards related to alcohol in India. International Journal of Science and Research Archive. https://doi.org/10.30574/ijsra.2021.3.2.0141
364. Maillard, R. (2017). La pratique du médecin généraliste dans la prévention de la consommation de cannabis chez les adolescents dans le Var.
365. Makovicky, P. J., Matlach, R., & Makovický, P. (2021). Lethal alcohol intoxications cases: thinking about the causes. Vnitřní lékařství. https://doi.org/10.36290/vnl.2021.132
366. Mali, S., & S.K.Bais (2023). DRUG-DRUG INTERACTIONS. EPRA International Journal of Research & Development (IJRD). https://doi.org/10.36713/epra12202
367. Malik, A. R., & D’Souza, D. C. (2006). Gone to Pot: The Association Between Cannabis and Psychosis.
368. Malnick, S., Maor, Y., & Neuman, M. G. (2022). Green Tea Consumption Is Increasing but There Are Significant Hepatic Side Effects. GastroHep. https://doi.org/10.1155/2022/2307486
369. Mandal, B. K. (2012). IS MARIJUANA A PRECURSOR TO ABUSE OF OTHER DRUGS. Journal of Pharmaceutical and Scientific Innovation.
370. Manghi, R., Broers, B., Khan, R., Benguettat, D., Khazaal, Y., & Zullino, D. (2009). Khat Use: Lifestyle or Addiction?. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2009.10400669
371. Manore, M. M. (2012). Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?. International Journal of Sport Nutrition and Exercise Metabolism. https://doi.org/10.1123/ijsnem.22.2.139
372. Marie, S. (2014). Society’s Chemical Noose: A Look at Substance Abuse and Suicide.
373. Martins, S. (2025). SUBSTANCE USE IN A UNIVERSITY POPULATION: THE IMPLICATIONS OF PERCEIVED SOCIAL ANXIETY AND DEPRESSION. https://doi.org/10.37602/ijebssr.2025.3303
374. Martins, S. R., Corrêa, P. C. R. P., Costa, C. B. F. D., Sousa, M. G. D., Tourinho, C. A. P., & Borges, V. L. G. (2025). Vaping cessation: how to treat nicotine dependence and tailor the nicotine replacement dose. A narrative review. Jornal Brasileiro de Pneumologia. https://doi.org/10.36416/1806-3756/e20250061
375. Martínez, M. T. L., & Meana, J. J. (2009). Cocaína: manejo de la adicción y los problemas derivados.
376. Masloman, S. K. (2020). Tinjauan Sosiologi Hukum Terhadap Penyalahgunaan Narkoba Di Kalangan Anggota Legislatif. JURNAL LEGALITAS. https://doi.org/10.33756/jelta.v13i01.7306
377. Mathai, D. S., Verrico, C. D., Shorter, D., Coverdale, J., & Kosten, T. R. (2016). “Just one bad high:” Considering synthetic cannabinoid outcome expectancies in adolescents. American Journal on Addictions. https://doi.org/10.1111/ajad.12457
378. Maughan, R. J., & Shirreffs, S. M. (2013). Alcohol, Exercise, and Sport. https://doi.org/10.1002/9781118692318.ch27
379. Mays, D., Gilman, S. E., Rende, R., Luta, G., Tercyak, K. P., & Niaura, R. (2014). Parental Smoking Exposure and Adolescent Smoking Trajectories. PEDIATRICS. https://doi.org/10.1542/peds.2013-3003
380. McBride, J. S., Altman, D. G., Klein, M.-L., & White, W. L. (1998). Green tobacco sickness. Tobacco Control. https://doi.org/10.1136/tc.7.3.294
381. McNeill, A. D., Brose, L. S., Calder, R. I., Hitchman, S. C., Hájek, P., & McRobbie, H. (2015). E-cigarettes: an evidence update. A report commissioned by Public Health England..
382. Mehta, S., & Vijay, T. (2023). Drugging Down on Life Athletes Clouding Their Minds through Substance Abuse. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2023.53328
383. Meier, M. H., Caspi, A., Knodt, A. R., Hall, W., Ambler, A., Harrington, H., Hogan, S., Houts, R., Poulton, R., Ramrakha, S., Hariri, A. R., & Moffitt, T. E. (2022). Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2021.21060664
384. Mendelsohn, C. (2012). Smoking and depression--a review.. PubMed.
385. Mendelsohn, C. (2015). Three Decades of High-Dose Nicotine Gum Dependence Treated With Nicotine Patches. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntv124
386. Menecier, P., Verny, M., Fernandez, L., & Ploton, L. (2016). Alcoholic abstinence in elderly subjects with misuse of alcohol. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2016.0600
387. Menezes, N. G. A., Silva, G. K. R. D., & Ferreira, C. S. (2014). Atuação do Enfermeiro Frente à Dependência Química da Cocaína.. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
388. Mermelstein, R., & Brikmanis, K. (2018). Nicotine and Tobacco Use. Routledge eBooks. https://doi.org/10.4324/9781315167534-9
389. Metrik, J. (2022). Alcohol and Cannabinoids - From the Editors. Alcohol research. https://doi.org/10.35946/arcr.v42.1.10
390. Mileva, B., Dikov, T., Goshev, M., Georgieva, M., Tsranchev, I. I., Angelov, M., Alexandrov, A., Ateriya, N., & Ivanova, V. (2024). Death Following Methyl Alcohol Intoxication: Gross Autopsy and Histological Findings. Cureus. https://doi.org/10.7759/cureus.65498
391. Miradj, S. (2020). Dampak Minuman Keras Terhadap Perilaku Generasi Muda (Gamsungi Kecamatan Ibu Selatan Kabupaten Halmahera Barat). AL-WARDAH. https://doi.org/10.46339/al-wardah.v14i1.245
392. Mirambeaux-Villalona, R., Granda‐Orive, J. I. D., Arroyo-Cózar, M., Calero-Pardo, S., Vaquero-Lozano, P., Vargas-Espinal, J. C., Sánchez-Carpintero, M., & Jiménez-Ruíz, C. A. (2025). Reducción hasta dejarlo: papel de la terapia sustitutiva con nicotina. https://doi.org/10.69703/pt.v27i1.4
393. Miranda, L. A., Leal, A. L. M. L., Santos, R. G. D., Dias, C. V., Ferreira, I. G. A., Oliveira, N. B. D., Gratão, A. L. S. M., Nobre, B. R. S., Carvalho, R., Batista, B. R. A., Carvalho, J. M. S. D., Borges, Y. O. O. C., Vial, T. F., Monteiro, P. F. D. S., & Canuto, M. M. D. G. (2024). EFEITOS CARCINOGÊNICOS E MUTAGÊNICOS DO CONSUMO DE ÁLCOOL SOBRE O TRATO GASTROINTESTINAL SUPERIOR: UMA REVISÃO DE LITERATURA. Brazilian Journal of Implantology and Health Sciences. https://doi.org/10.36557/2674-8169.2024v6n5p415-427
394. Miranda, N. R., Riaño, D. N., Estrada, E. M., & Espinosa, F. Á. (2017). Vivir con luz. No a las drogas. Revista Boletín Redipe.
395. Misra, M., Shulman, D. I., & Weiss, A. (2013). Anorexia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.98.5.zeg35a
396. Mn, H., Sutradhar, S. R., Sm, A., & Ih, C. (2016). An Unusual Case of Suicide Attempt Using Intravenous Injection of Kerosene.. PubMed.
397. Mohajan, D., & Mohajan, H. K. (2023). Binge-Eating: A Life-Threatening Eating Disorder. Innovation in Science and Technology. https://doi.org/10.56397/ist.2023.07.06
398. Moreira, M. J., Barroso, F. M. C., Sá, D. B. D., & Rocha, M. F. (2018). DANOS OROFACIAIS CAUSADOS PELO USO EXCESSIVO DA COCAÍNA: UMA PERSPECTIVA DO CENÁRIO BRASILEIRO. Jornada Odontológica dos Acadêmicos da Católica.
399. Morera, A., & Díaz-Mesa, E. (2016). Nalmefene as an intermittent treatment for alcohol abuse triggering cocaine and sex consumption. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1057
400. Morgan, C. J. A. (2009). Differential Effects of THC and CBD in Cannabis Smokers. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70268-8
401. Morgan, F., Weightman, A., Morgan, H., Whitehead, S., Carter, B., Jones, S. L., Byrne, E., & Turley, R. (2013). Tobacco: harm-reduction approaches to smokingShort title: Tobacco: harm reduction.Review 3: The effectiveness of long-term harm reduction approaches without the prior intentionof quitting.
402. Morgan, F., Weightman, A., Whitehead, S., Morgan, H., Carter, B., Byrne, E., Turley, R., & Cleves, A. (2012). Tobacco: harm-reduction approaches to smokingShort title: Tobacco: harm reduction.Review 2: The effectiveness of tobacco harm reduction approaches with the intention of quitting(i.e. ‘cutting down to quit’ or ‘reduction to stop smoking’), with and without assistance.
403. Morgan, G. (2015). Does Utilitarian Policy such as Smoking Cessation Lend Support to Wider Aspirin Use?. AIMS Public Health. https://doi.org/10.3934/publichealth.2015.2.223
404. Moroianu, L.-A., Moroianu, M., & Ciubară, A. (2021). FROM MARIJUANA TO INTERNET AND VIDEO GAMING ADICTION- A CASE REPO. Archiv Euromedica. https://doi.org/10.35630/2199-885x/2021/11/5.15
405. Morris, P. E., Vargo, L. A., & Buckner, J. D. (2024). Social Anxiety and Cannabis-Related Problems: The Serial Roles of Distress Tolerance and Cannabis Use Motives. Substance Use & Misuse. https://doi.org/10.1080/10826084.2024.2320400
406. Mosquera, J. T., & Menéndez, M. C. (2006). Alcohol etílico: un tóxico de alto riesgo para la salud humana socialmente aceptado. Revista de la Facultad de Medicina.
407. Mullen, C., Whalley, B. J., Schifano, F., & Baker, J. S. (2020). Anabolic androgenic steroid abuse in the United Kingdom: An update. British Journal of Pharmacology. https://doi.org/10.1111/bph.14995
408. Mulyadi, A., Laksanano, G. S., Prihandana, S., & Cholis, N. (2025). PEMBERDAYAAN REMAJA DALAM UPAYA PENCEGAHAN PENYALAHGUNAAN NARKOBA DI KELURAHAN DEBONG KULON KOTA TEGAL. https://doi.org/10.31983/jimat.v2i1.12042
409. Murray, R., Quigley, H., Quattrone, D., Englund, A., & Forti, M. D. (2016). Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry. https://doi.org/10.1002/wps.20341
410. Murray, T. H. (2020). The Coercive Power of Drugs in Sports. Routledge eBooks. https://doi.org/10.4324/9781003075004-4
411. Ménétrey, A., Augsburger, M., Giroud, C., & Mangin, P. (2001). [Cannabis and automobile driving].. PubMed.
412. Mørland, J., Bretteville‐Jensen, A. L., & Bramness, J. G. (2022). On the duration of cannabis effects and the presence of THC in the body. Addiction. https://doi.org/10.1111/add.16080
413. Nachiappan, A. C., & Selvavinayagam, T. S. (2017). E-cigarettes: promise or threat?. International Journal of Community Medicine and Public Health. https://doi.org/10.18203/2394-6040.ijcmph20173710
414. Nahvi, S., & Rastegar, D. A. (2020). Nicotine and Tobacco. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0007
415. Nascimento, O. V. D., Otani, C., Jesus, I. F. D., Cavalcanti, V., & Almeida, S. C. D. (2025). GUARANÁ (Paullinia Cupana): SUPLEMENTAÇÃO EM PRATICANTES DE ATIVIDADES FÍSICA E ATLETAS. Editora Científica Digital eBooks. https://doi.org/10.37885/250118712
416. Nayır, E., Karacabey, B., Kırca, Ö., & Özdoğan, M. (2016). Electronic cigarette (e-cigarette). Journal of Oncological Sciences. https://doi.org/10.1016/j.jons.2016.04.001
417. Neuspiel, D. R. (2012). Marijuana. Pediatrics in Review. https://doi.org/10.1542/pir.33.7.333
418. Nierengarten, M. M. B. (2016). Talking to teens about marijuana. Contemporary pediatrics.
419. Nieto-Morales, C. (2012). MENORES, JÓVENES, EDUCACIÓN, DROGAS Y JUSTICIA JUVENILES, YOUNG PEOPLE, EDUCATION, DRUGS AND JUSTICE.
420. Nieva, G. (2015). Tractament del tabaquisme: psicopatologia i personalitat. TDX (Tesis Doctorals en Xarxa).
421. Nikoloutsou, I., Vasileiou, V., Litsiou, E., Kolokytha, S., Tsoutsa, A., Zakynthinos, S., & Κatsaounou, P. (2014). Smoking cessation changes basic metabolism, body weight, leptin and insulin levels, adipose tissue percentage, index of insulin resistance and index of insulin secretion. Tobacco Induced Diseases. https://doi.org/10.1186/1617-9625-12-s1-a24
422. Nolder, K. A., & Anderson, K. G. (2023). Effects of acute and chronic nicotine administration on probability discounting. Behavioural Pharmacology. https://doi.org/10.1097/fbp.0000000000000753
423. Nordstrom, B. R., & Levin, F. R. (2008). Substance Abuse: Cannabis‐Related Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch57
424. Nurhayati, M., & Faridah, H. (2022). ANALISIS DAN KAJIAN KRIMINOLOGI HUKUM DALAM KASUS MINUMAN BERAKHOL PADA ANAK DIBAWAH UMUR DI DESA MULYASARI. The Juris. https://doi.org/10.56301/juris.v6i2.598
425. Nygaard, I., Bryant, C. M., Dowell, C., & Wilson, D. (2002). Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd003505
426. ODEN, M. S. (2015). If Drug Abuse Is the Answer, Then What Is the Question?. Routledge eBooks. https://doi.org/10.1201/b19237-14
427. Oliveira, C. B. D., & Souza, M. R. D. (2013). Dependência química do 'crack' como gerador da criminalidade no âmbito patrimonial. Revista Brasileira de Direito e Gestão Pública.
428. Oliveros, L. M., Noda, D. O., Delgado, Z. P., & Hernández, C. G. (2018). Consideraciones sobre las adicciones en la formación del profesional de Ciencias Médicas. Revista Médica Electrónica.
429. Olson, J., Aryitey, W., & Costanzo, R. (2020). Nicotine: From plants to people. Medicinska rec. https://doi.org/10.5937/medrec2003142o
430. Oró, M., & Pére, D. (2013). Sense passar-se de la ratlla la normalització dels consums recreatius de drogues. TDX (Tesis Doctorals en Xarxa).
431. Osibogun, O., Li, W., Jebai, R., & Kalan, M. E. (2024). Cigarettes and e-cigarettes use among US adults with multimorbidity. Drug and Alcohol Dependence Reports. https://doi.org/10.1016/j.dadr.2024.100231
432. Ours, J. C. V., & Williams, J. (2014). Cannabis Use and Its Effects on Health, Education and Labor Market Success. RePEc: Research Papers in Economics.
433. Ours, J. C. V., & Williams, J. (2014). Cannabis Use and its Effects on Health, Education and Labor Market Success. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.2414469
434. OZTRK, O., Selçuk, M. Y., Yalçın, B. M., & NAL, M. (2016). DOES SELF-CONTROL MEAN EVERYTHING FOR SMOKING CESSATION?. Turkish Journal of Family Medicine & Primary Care. https://doi.org/10.5455/tjfmpc.213976
435. Papke, R. L., & Picciotto, M. R. (2012). Nicotine Dependence and Depression, What is the Future for Therapeutics?. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.1000e105
436. Pardo, G., & Pilar, M. (2015). Influences of social stress in the rewarding effects of mdma and alcohol.
437. Park, J., & Kim, H. (2019). 장단기 고용량 카페인 투여가 청소년기 동물모델의 행동에 미치는 영향. Journal of Korean Biological Nursing Science.
438. Parker, C. (2023). Providing Patients Caffeinated Coffee in PICUS. Journal of Psychiatric Intensive Care. https://doi.org/10.20299/jpi.2023.007
439. Parrott, A. C. (1999). Does cigarette smoking cause stress?. American Psychologist. https://doi.org/10.1037//0003-066x.54.10.817
440. Patel, G., & Kashyap, A. (2023). Tobacco addiction and infertility in India: an overview. International Journal of Reproduction Contraception Obstetrics and Gynecology. https://doi.org/10.18203/2320-1770.ijrcog20232318
441. Pathak, V. K., Kanuja, & Chamola, S. K. (2023). Association of hypertension with consumption of energy drinks in an adolescent male. International Journal of Community Medicine and Public Health. https://doi.org/10.18203/2394-6040.ijcmph20231300
442. Patil, H., Lavie, C. J., & O’Keefe, J. H. (2011). Cuppa joe: friend or foe? Effects of chronic coffee consumption on cardiovascular and brain health.. Missouri medicine.
443. Patnaik, S. (2023). Consequence of Use of Alcoholic Beverages in Modern Life-Style and Remedy with Yoga and Ayurveda. Journal of Natural & Ayurvedic Medicine. https://doi.org/10.23880/jonam-16000388
444. Patten, T., Dreier, A., Herman, R. J., Kimball, B. A., & Biasi, M. D. (2021). Exposure to fruit-flavoring during adolescence increases nicotine consumption and promotes dose escalation. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2021.01.12.426210
445. Pearlson, G. D. (2002). Functional Neuroimaging of Cannabinoid Effects. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-165-7_17
446. Pedersen, E. R., Tucker, J. S., Seelam, R., Rodriguez, A., & D’Amico, E. J. (2019). Factors Associated With Acquiring a Medical Marijuana Card: A Longitudinal Examination of Young Adults in California. Journal of Studies on Alcohol and Drugs. https://doi.org/10.15288/jsad.2019.80.687
447. Pedrosa, S. M. (2016). O uso nocivo de crack: percepções de pessoas em tratamento da dependência.
448. Peltier, M. R., Flores, J. M., Smith, P. H., Roberts, W., Verplaetse, T. L., Moore, K. E., Hacker, R. L., Oberleitner, L., & McKee, S. A. (2019). Smoking Across the Menopausal Transition in a 10-Year Longitudinal Sample: The Role of Sex Hormones and Depressive Symptoms. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntz069
449. Pendleton, M., Brown, S. D., Thomas, C. M., & Odle, B. (2012). Potential Toxicity of Caffeine When Used as a Dietary Supplement for Weight Loss. Journal of Dietary Supplements. https://doi.org/10.3109/19390211.2012.736460
450. Pendleton, M., Brown, S. D., Thomas, C. M., & Odle, B. (2013). Potential Toxicity of Caffeine when Used as a Dietary Supplement for Weight Loss. Journal of Dietary Supplements. https://doi.org/10.3109/19390211.2012.758215
451. Pericot‐Valverde, I., García–Rodríguez, O., Rus‐Calafell, M., Fernández‐Artamendi, S., Ferrer‐García, M., & Gutiérrez‐Maldonado, J. (2013). Peak Provoked Craving After Smoking Cessation. Studies in health technology and informatics. https://doi.org/10.3233/978-1-61499-282-0-163
452. Perkins, K. A., Fonte, C., Ashcom, J., Broge, M., & Wilson, A. (2001). Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/1064-1297.9.1.91
453. Perriot, J., Peiffer, G., & Underner, M. (2021). [Tobacco and cannabis consumption : toxicity and management of quitting]..
454. Perriot, J., Underner, M., Chapot, E., & Peiffer, G. (2023). Tobacco and cannabis co-use : toxicity, dependence and cessation management.. SCIREA Journal of Health. https://doi.org/10.54647/pmh330309
455. Pesta, D., Angadi, S. S., Burtscher, M., & Roberts, C. K. (2013). The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance. Nutrition & Metabolism. https://doi.org/10.1186/1743-7075-10-71
456. Petekkaya, S., Ayaz, N., Doğan, M., Oruç, M., Öner, B. S., Göktürk, C., Çelebi, A., Budak, A., Soylu, Ö., & Çelbiş, O. (2016). A Case of Sudden Death due to Lighter Refill Gas Inhalation / Cakmak Gazi Inhalasyonuna Bagli Ani Gelisen Olum Olgusu. Journal of Turgut Ozal Medical Center. https://doi.org/10.5455/jtomc.2015.2885
457. Petry, J., Gournay, L. R., Bilsky, S. A., Hill, M. A., Feldner, M. T., Peters, E. N., Bonn‐Miller, M. O., & Leen‐Feldner, E. W. (2023). Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study. Cannabis and Cannabinoid Research. https://doi.org/10.1089/can.2022.0317
458. Phillips, J., Lim, F., & Hsu, R. (2016). Synthetic cannabinoid poisoning. Nursing. https://doi.org/10.1097/01.nurse.0000502753.33570.52
459. Piontek, D., Kraus, L., Pabst, A., & Müller, S. (2009). Verbreitung und Einflussfaktoren cannabisbezogener Probleme bei Jugendlichen. Suchttherapie. https://doi.org/10.1055/s-0029-1240270
460. Piotrowicz, K., Piotrowicz, H., Kurzeja, J., Bajkacz, A., Kraśnik, W., Jankowska, O., Rogala, A., & Osmólska, J. (2025). Longevity Recipe - Lifestyle Influences on the Quantity and Quality of Life. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2025.77.56972
461. Plawecki, M. H., White, K., Kosobud, A., Grahame, N. J., Zimmermann, U., Crabb, D. W., & O’Connor, S. (2018). Sex Differences in Motivation to Self‐Administer Alcohol After 2 Weeks of Abstinence in Young‐Adult Heavy Drinkers. Alcoholism Clinical and Experimental Research. https://doi.org/10.1111/acer.13860
462. Plumber, N., Majeed, M., Ziff, S., Thomas, S., Bolla, S. R., & Gorantla, V. R. (2021). Stimulant Usage by Medical Students for Cognitive Enhancement: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.15163
463. Poling, J., Sewell, R. A., & Sofuoglu, M. (2009). The Effect of Cannabis Compared with Alcohol on Driving. American Journal on Addictions. https://doi.org/10.1080/10550490902786934
464. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., & Raciti, C. (2013). A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduction Journal. https://doi.org/10.1186/1477-7517-10-19
465. Pope, H. G., & Yurgelun‐Todd, D. (2004). Residual cognitive effects of long-term cannabis use. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543630.015
466. Powers, J. M., LaRowe, L. R., Rubenstein, D., Paice, J. A., Hitsman, B., & Rini, C. (2025). Relationship between pain and nonopioid substance use in two national samples of cancer survivors. Cancer. https://doi.org/10.1002/cncr.35701
467. Poznański, M., Pietras, T., & Antczak, A. (2017). A Debate: Can We Recommend Electronic Cigarettes to Our Patients? Opinion 2. Advances in respiratory medicine. https://doi.org/10.5603/arm.2017.0008
468. pratiwi, W. P. A. (2021). Penyalah gunaan narkoba di kalangan remaja. https://doi.org/10.31219/osf.io/z9n4s
469. Prensky, E. H., Cohen, L. M., McChargue, D. E., & Gao, W. (2010). Effects of Sensory and Behavioral Substitutes Following an Experimentally Induced Stressor among Abstinent Smokeless Tobacco Users. American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2009.00019.x
470. Priyadarshi, S., Tangade, P., Sahar, N., Roy, D., & Dalai, S. (2021). Tobacco: a menace impending ‘Tobacco kills, don’t be duped. International Journal of Applied Dental Sciences. https://doi.org/10.22271/oral.2021.v7.i2g.1245
471. Prokopchuk, O., Neumann, P., Hüser, N., Friess, H., & Wilhelm, D. (2019). Multiple intestinal intussusceptions caused by highly impaired gastrointestinal motility in a patient with chronic cannabis consumption. Journal of Surgical Case Reports. https://doi.org/10.1093/jscr/rjz160
472. Puente, E. O. V., Ángel-García, J. E. D., Méndez, A. P. C., Cisneros, M. A. L., González, S. C. E., & Mata, J. L. V. (2025). Reflexología Facial para Reducir el Estrés y Consumo de Alcohol en Adultos Mexicanos. Revista Veritas de Difusão Cientifica.. https://doi.org/10.61616/rvdc.v6i2.810
473. Pytell, J. D., & Rastegar, D. A. (2020). Cannabinoids. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0010
474. Pöğün, Ş., & Collins, A. C. (2012). Oral Nicotine Self-Administration in Rodents. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.s2-004
475. Qasim, H., Alarabi, A. B., Alzoubi, K. H., Karim, Z. A., Alshbool, F. Z., & Khasawneh, F. T. (2019). The effects of hookah/waterpipe smoking on general health and the cardiovascular system. Environmental Health and Preventive Medicine. https://doi.org/10.1186/s12199-019-0811-y
476. Quittschalle, J., Pabst, A., Löbner, M., Heser, K., Wagner, W., Hajak, A., König, H., Luppa, M., & Riedel‐Heller, S. G. (2021). Wie wirken sich Alkohol- und Tabakkonsum auf die Entwicklung einer Depression im Alter aus? Ergebnisse einer quantitativen Untersuchung hochaltriger Frauen und Männer. Das Gesundheitswesen. https://doi.org/10.1055/s-0041-1732016
477. R.Kleiman, M. A., & Iwry, J. M. (2017). A Nudge Toward Temperance: User-Set Consumption Limits as an Element of Cannabis Policy. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3166307
478. R.Kleiman, M. A., Jones, T. J., Miller, C., & Halperin, R. (2018). Driving While Stoned: Issues and Policy Options. Journal of Drug Policy Analysis. https://doi.org/10.1515/jdpa-2018-0004
479. Raja, K., Suthamancharri.S, Vaishnavi.S, Soundarya.S.P, & Fathima, S. (2023). Review on Effects of Passive Smoking. International Journal of Community Dentistry. https://doi.org/10.56501/intjcommunitydent.v11i1.777
480. Rakhmatullayev, A., Oltiyev, E., Boltayeva, Z., Khalimova, D., Umarova, M., & Jarilkasinova, G. (2025). Environmental aspects of exposure to tobacco smoke and methods for reducing its harm to the environment and human health. E3S Web of Conferences. https://doi.org/10.1051/e3sconf/202561404003
481. Ramaiah, V. V., Ss, M. A. R., Alfawzan, A. A., Mulla, M., Babaji, P., & Hr, L. S. (2020). Oral manifestations and oral health care among the illicit drug abusers: A review. Journal of Critical Reviews.
482. Ramu, B., & Mounika, I. (2018). Lifestyle drugs: concept and impact on society. Journal of Human Virology & Retrovirology. https://doi.org/10.15406/jhvrv.2018.06.00194
483. Rao, R., Velayudhan, L., Creese, B., Aarsland, D., Lewis, C. M., Kalafatis, C., Khan, Z., Corbett, A., & Ballard, C. (2024). Daily cannabis use and cognitive impairment in community residents aged 50 and over. Journal of Substance Use. https://doi.org/10.1080/14659891.2024.2365173
484. Rath, M. (2012). Energy drinks: What is all the hype? The dangers of energy drink consumption. Journal of the American Academy of Nurse Practitioners. https://doi.org/10.1111/j.1745-7599.2011.00689.x
485. Rathee, S. (2021). Executive Functions in Cannabis Users: A Comparative Study. Journal of Anxiety & Depression. https://doi.org/10.46527/2582-3264.134
486. Ray, A., & Mohapatra, D. (2019). Life Threatening Effects of Oral Habits. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2019.03647.7
487. Reardon, C. L., & Creado, S. (2014). Drug abuse in athletes. Substance Abuse and Rehabilitation. https://doi.org/10.2147/sar.s53784
488. Redpath, S., & George, A. (2008). Health and Medicinal Benefits of Persimmon Fruit : A Review. Advances in Horticultural Science. https://doi.org/10.1400/100649
489. Rella, J. G. (2015). Recreational cannabis use: Pleasures and pitfalls. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.82a.14073
490. Ribeiro, B. M. D. S. S., & Teston, É. F. (2017). A UTILIZAÃ‡ÃƒO DE COCAÃNA DURANTE A GESTAÃ‡ÃƒO E AS CONSEQUÃŠNCIAS PARA CRIANÃ‡A.
491. Ribeiro, B. M. D. S. S., & Teston, É. F. (2017). A UTILIZAÇÃO DE COCAÍNA DURANTE A GESTAÇÃO E AS CONSEQUÊNCIAS PARA CRIANÇA.
492. Ribeiro, M. A., Júnior, E. E. D. M., Brito, C. R. D. S., Paixão, A. G. D., Costa, D. G. M. D., Alves, V. L. D. S., Freitas, D. G. D., Costa, M. A. R. D., Filho, I. J. D. S., & Oliveira, R. F. D. (2024). Impacts of caffeine consumption in the workplace: from moderate use to dependence. Concilium. https://doi.org/10.53660/clm-3670-2409
493. Riczker, A. S., & Echanique, M. E. (2017). Acciones y efectos del etanol y las bebidas alcohólicas durante la adolescencia y juventud. Revista de la Facultad de Ciencias Médicas (Quito).
494. Ritonga, D. R., Khairunsyah, K., Sinaga, N. S., Rafly, M., Ginting, R., & Wahyudi, W. (2025). Gambaran Kebiasaan Merokok dan Paparan Rokok pada Remaja di Indonesia. Jurnal Ilmu Kedokteran dan Kesehatan Indonesia. https://doi.org/10.55606/jikki.v5i2.6124
495. Roberts, J. R. (2021). In Focus. Emergency Medicine News. https://doi.org/10.1097/01.eem.0000791944.22265.da
496. Rocha, A. I. V., Hernández, R. T., Ortega, C. A., & Mora, O. A. C. (2017). Madre inhaladora de canabinoides; un problema, un reto y lo que debemos considerar; reporte de un caso. Anestesia en México.
497. Rocha, M. I. D. U. M. D., Lera, J. P. B., Jardim, G. B. G., Mucellini, A. B., Cirolini, L., Jung, I. E. D. C., Mânica-Cattani, M. F., Silveira, A. F. D., Filho, O. C. D. S., & Cruz, I. B. M. D. (2010). Lifestyle, health characteristics and alcohol abuse in young adults who are non-daily smokers. Sao Paulo Medical Journal. https://doi.org/10.1590/s1516-31802010000600008
498. Rodak, K., Kokot, I., & Kratz, E. M. (2021). Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe?. Nutrients. https://doi.org/10.3390/nu13093088
499. Rodrigues-Silva, N. (2012). Chocolate: Psychopharmacological Aspects, Mood, and Addiction. Humana Press eBooks. https://doi.org/10.1007/978-1-61779-803-0_31
500. Rodriguez, K. N. P., Jalca, A. D. C., Mero, A. R. P., & Loor, J. O. O. (2023). Consumo de sustancias ilícitas en jóvenes y sus alteraciones en el sistema nervioso.. Revista Científica Higía de la Salud. https://doi.org/10.37117/higia.v8i1.744
501. Rodriguez, M. G. P., & cvu (2016). Mariguana: ¿por qué tanta controversia?.
502. Rodríguez, M. E., & Anglin, M. D. (1988). The Epidemiology of Alcohol Consumption in Spain. International Journal of Social Psychiatry. https://doi.org/10.1177/002076408803400203
503. Rodríguez‐Arias, M., Navarrete, F., Arenas, M. C., Aguilar, M., Rubio, G., Miñarro, J., & Manzanares, J. (2015). SY29-3SOCIAL DEFEAT IN ADOLESCENT MICE INCREASES VULNERABILITY TO ALCOHOL CONSUMPTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agv076.120
504. Rogers, T., Milkman, K. L., & Volpp, K. G. (2014). Commitment Devices. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000455018.85064.22
505. Rohsenow, D. J., & Monti, P. M. (1999). Does urge to drink predict relapse after treatment?. PubMed.
506. Rommelse, N. (2012). Life before birth: are the dice tossed for the rest of our lives?. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-012-0264-y
507. Roy‐Byrne, P. (2016). Cannabis Abuse May Blunt the Brain's Response to Stimulant Challenge. Journal watch. https://doi.org/10.1056/nejm-jw.na41435
508. Ruiz‐Contreras, A. E., Ortega-Mora, I., Amancio‐Belmont, O., Méndez‐Díaz, M., & García, Ó. P. (2016). Mariguana y sus efectos sobre el cerebro, la toma de decisiones y la inteligencia. Una revisión narrativa. Revista Internacional de Investigación en Adicciones. https://doi.org/10.28931/riiad.2016.2.06
509. S.Bade, S., & Deo, S. V. S. (2025). A case study of effect of dravyas from Ekasara gana on tobacco addiction withdrawal symptoms. International Journal of Ayurvedic Medicine. https://doi.org/10.47552/ijam.v15i4.4867
510. Sahu, R., Shah, K., Malviya, R., Paliwal, D., Sagar, S., Singh, S., Prajapati, B. G., & Bhattacharya, S. (2023). E-Cigarettes and Associated Health Risks: An Update on Cancer Potential. Advances in respiratory medicine. https://doi.org/10.3390/arm91060038
511. Sahu, S., Nagarajappa, R., Sahoo, K., Naik, D., Sahu, N., Kiran, K., & Tutor, S. (2020). Vaping: Realities in its Effect on Oral Health. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v14i4.13079
512. Saitz, R. (2002). Cannabis Use Linked with Cognitive Impairment. Journal watch. https://doi.org/10.1056/jd200204300000015
513. Samarth, D. (2019). Marijuana: Indian scenario. Annals of Psychiatry and Treatment. https://doi.org/10.17352/apt.000011
514. Sanctis, V. D., Soliman, N., Soliman, A., Elsedfy, H., Maio, S. D., Kholy, M. E., & Fiscina, B. (2017). Caffeinated energy drink consumption among adolescents and potential health consequences associated with their use: a significant public health hazard.. PubMed. https://doi.org/10.23750/abm.v88i2.6664
515. Sansone, L., Milani, F., Fabrizi, R., Belli, M., Cristina, M., Zagà, V., Iure, A. D., Cicconi, L., Bonassi, S., & Russo, P. (2023). Nicotine: From Discovery to Biological Effects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914570
516. Santos, A. D. C. C. D., Kisanucki, G. F., & Barbosa, F. K. (2016). Uso medicinal da Cannabis (CBD). UNILUS Ensino e Pesquisa.
517. Saputra, D. A., & Amin, M. M. (2023). Synthetic tobacco dependence: a case report from Bintang mountains, Papua, Indonesia. Advances in health sciences research/Advances in Health Sciences Research. https://doi.org/10.2991/978-94-6463-310-8_10
518. Saravi, S. S. S., Shokrzadeh, M., & Tahmasbi, M. (2009). Inhibition of morphine dependence by Withania coagulans in mice. Planta Medica. https://doi.org/10.1055/s-0029-1234763
519. Sattout, A. H., & Nicol, M. F. (2009). Cardiac arrest following cannabis use: a case report. Cases Journal. https://doi.org/10.1186/1757-1626-2-208
520. Schiffman, S. S., Zervakis, J., Graham, B. G., & Westall, H. L. (2002). Age-Related Chemosensory Losses: Effect of Medications. ACS symposium series. https://doi.org/10.1021/bk-2002-0825.ch008
521. Schlagintweit, H. E., & Barrett, S. P. (2016). Does acute tobacco smoking prevent cue-induced craving?. Journal of Psychopharmacology. https://doi.org/10.1177/0269881116639288
522. Schrieks, H. F. H. I. C. (2015). Adolescent Alcohol Consumption: Brain Health Outcomes. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000238
523. Schulze, J. J., Rane, A., & Ekström, L. (2009). Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425250902976862
524. Scripcaru, C., Iliescu, D. B., Iov, T., & Scripcaru, A. (2022). Alcohol consumption - Antisocial effects and legislative protocols. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2022.1.03
525. Semwal, V., & Patil, M. S. (2022). Role of Yoga in Drugs Abuse. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-4858
526. Seol, W., Kim, H. J., & Son, I. (2021). Effect of Coffee, Tobacco, and Alcohol on Parkinson’s Disease. Journal of the Korean Neurological Association. https://doi.org/10.17340/jkna.2021.3.3
527. Shah, K. T. B. M. (2018). Drug in The Workplace. https://doi.org/10.2991/acpch-17.2018.54
528. Sharma, G., & Nagpal, A. (2015). Tobacco based dentifrices: still not squeezed out. Journal of Family Medicine and Primary Care. https://doi.org/10.4103/2249-4863.154680
529. Sharma, M., bairwa, J. P., & Goyal, S. (2025). Role of Ayurveda in the Management of Alcohol Addiction: A Case Report. International Research Journal of Ayurveda & Yoga. https://doi.org/10.48165/irjay.2025.80505
530. Shasho, R., & Shasho, M. (2022). Diagnostic Approach Common Cases of Vitamins Toxicity in Children. Scholars Journal of Applied Medical Sciences. https://doi.org/10.36347/sjams.2022.v10i01.001
531. Shazzad, M. N., Abdal, S. J., Majumder, M. S. M., Sohel, J. U. A., Ali, S. M. M., & Ahmed, S. (2014). Drug Addiction in Bangladesh and its Effect. Medicine Today. https://doi.org/10.3329/medtoday.v25i2.17927
532. Sheikh, T. N. (2024). NICOTINE/CAFFEINE: PROPINQUITY TO BE DIVULGE IN THE DOMAIN OF SCIENCE AND TECHNOLOGY. https://doi.org/10.58532/v3bjcs6p1ch4
533. Shimmi, S. C. (2025). Clouds of Harm: The Health Impact of Youth Vaping in Malaysia. Borneo Journal of Medical Sciences (BJMS). https://doi.org/10.51200/bjms.v19i3.6686
534. Shirley, T. (2020). Treatment Compliance for Drug addiction. Journal of Clinical Toxicology.
535. Shorey-Fennell, B., Magnan, R. E., Ladd, B. O., & Fales, J. (2021). What’s Pain Got To Do With It?: Young Adults With and Without Chronic Pain Perceive Minimal Risks and Moderate Benefits from Cannabis Use. https://doi.org/10.26828/cannabis.2021.01.000.9
536. Silverman, K., Evans, S. M., Strain, E. C., & Griffiths, R. R. (1992). Withdrawal Syndrome after the Double-Blind Cessation of Caffeine Consumption. New England Journal of Medicine. https://doi.org/10.1056/nejm199210153271601
537. Simpkins, A. M., & Simpkins, C. A. (2016). Meditations for Substance Abuse. https://doi.org/10.1002/9781119171690.ch19
538. Singh, L., Joshi, T., Tewari, D., Echeverría, J., Mocan, A., Sah, A. N., Parvanov, E. D., Tzvetkov, N., Feei, Z., Lee, Y. Y., Poznański, P., Huminiecki, Ł., Sacharczuk, M., Jóźwik, A., Horbańczuk, J. O., Feder‐Kubis, J., & Atanasov, A. G. (2020). Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01593
539. Singh, N., Wanjari, A., & Sinha, A. H. (2023). Effects of Nicotine on the Central Nervous System and Sleep Quality in Relation to Other Stimulants: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.49162
540. Sitorus, R. J. (2016). PENGGUNAAN NARKOTIKA MENDUKUNG PERILAKU-PERILAKU BERISIKO. Jurnal Ilmu Kesehatan Masyarakat.
541. Skelton, K. R., & Young‐Wolff, K. C. (2022). Preconception cannabis use: An important but overlooked public health issue. Women s Health. https://doi.org/10.1177/17455057221124071
542. Skemp, K. M., Berens, A., & Mohapatra, S. (2023). Examining the Prevalence of Disordered Eating among Menopausal and Post-Menopausal Women. https://doi.org/10.31038/awhc.2023614
543. Smiley, S. L., DeAtley, T., Rubin, L. F., Harvey, E., Kierstead, E. C., Hooper, M. W., Niaura, R., Abrams, D. B., & Pearson, J. (2017). Early Subjective Sensory Experiences with “Cigalike” E-cigarettes Among African American Menthol Smokers: A Qualitative Study. Nicotine & Tobacco Research. https://doi.org/10.1093/ntr/ntx102
544. Smith, D. E., & Seymour, R. B. (1998). CANNABIS ADDICTION AND WITHDRAWAL: ATTITUDES AND IMPLICATIONS. CRC Press eBooks. https://doi.org/10.1201/9780203304228-17
545. Sofah, R., Harlina, H., Putri, R. M., & Afriyanti, V. (2017). MENGEMBANGKAN PERILAKU ASERTIF UNTUK PENCEGAHAN PENYALAHGUNAAN NARKOBA.
546. Sofi, G., Mujassam, M., & Alam, M. A. (2023). Exploring Drug De-addiction Treatment in Unani Medicine.. PubMed.
547. Solimini, R., Busardò, F. P., Rotolo, M. C., Ricci, S., Mastrobattista, L., Mortali, C., Graziano, S., Pellegrini, M., Luca, N. M. D., & Palmi, I. (2017). Hepatotoxicity associated to synthetic cannabinoids use.. PubMed.
548. Song, J. H., Xu, H., Liu, F., & Feng, L. (2011). Tea and cognitive health in late life: Current evidence and future directions. The journal of nutrition health & aging. https://doi.org/10.1007/s12603-011-0139-9
549. Spezzia, S. (2020). MANIFESTAÇÕES BUCAIS CAUSADAS PELO TABAGISMO..
550. Spinazzola, E., Forti, M. D., & Murray, R. (2023). Which Cannabis Users Develop Psychosis?. Cambridge University Press eBooks. https://doi.org/10.1017/9781108943246.016
551. Srivastava, K., Ghoge, S., Sahu, A. C., & Rathod, H. (2023). Community Alcoholic - A Ticking Bomb. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2023.v35i03.026
552. Stein, R. J., Pyle, S. A., Haddock, C. K., Poston, W. S. C., Bray, R. M., & Williams, J. (2008). Reported Stress and Its Relationship to Tobacco Use among U.S. Military Personnel. Military Medicine. https://doi.org/10.7205/milmed.173.3.271
553. Steinberg, M. L., & Williams, J. M. (2013). Extinction Burst after Varenicline Titration: A Case Report. The Journal of Smoking Cessation. https://doi.org/10.1017/jsc.2013.7
554. Steinberg, M., Schmelzer, A. C., Richardson, D., & Foulds, J. (2008). The Case for Treating Tobacco Dependence as a Chronic Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-7-200804010-00012
555. Stensel, D. J., King, J. A., & Thackray, A. E. (2016). Role of physical activity in regulating appetite and body fat. Nutrition Bulletin. https://doi.org/10.1111/nbu.12234
556. Stevenson, R. J., & Francis, H. (2023). Food-Related Drugs and Food as a Drug. Cambridge University Press eBooks. https://doi.org/10.1017/9781108755399.008
557. Stockley, C. S. (2016). Wine consumption, cognitive function and dementias – A relationship?. Nutrition and Aging. https://doi.org/10.3233/nua-150055
558. Stogner, J. M., & Miller, B. L. (2015). The Dabbing Dilemma: A Call for Research on Butane Hash Oil and Other Alternate Forms of Cannabis Use. Substance Abuse. https://doi.org/10.1080/08897077.2015.1071724
559. Stone, M. H. (2015). Marijuana and Psychosis: The Effects of Adolescent Abuse of Marijuana and other Drugs in a Group of Forensic Psychiatric Patients. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000188
560. Straussner, S. L. A., Straussner, S. B., & Einstein, S. (2012). Alcohol Use Disorder. Social Work. https://doi.org/10.1093/obo/9780195389678-0025
561. Strong, S., Thomas, H. A., Adams, Z. W., & Hulvershorn, L. A. (2025). Comorbid Cannabis Use and Mood Disorders Among Adolescents. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20240049
562. Suman, L. N. (2012). Substance Use: A Psychosocial Perspective. Indian journal of clinical psychology.
563. Surati, L., Arya, A., Nehra, V., Chaudhari, B., & Saldanha, D. (2021). Polysubstance abuse in adolescence. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.328867
564. Surma, S., Romańczyk, M., Fojcik, J., & Krzystanek, M. (2020). Kawa — lekarstwo, używka i narkotyk. Psychiatria. https://doi.org/10.5603/psych.a2020.0031
565. Szocs, C., Biswas, D., & Borges, A. (2016). Cheers to Haptic Sensations and Alcohol Consumption: How Glassware Weight Impacts Perceived Intoxication and Positive Emotions. Journal of the Association for Consumer Research. https://doi.org/10.1086/688219
566. Sánchez, C. E. P., Gaibor, M. P. A., Cruz, R. E. B., Chuquimarca, R. C., & Armijo, J. A. V. (2018). FACTORES ASOCIADOS AL CONSUMO DE DROGAS EN ADOLESCENTES DE LA PARROQUIA CAMILO PONCE DE LA CIUDAD DE BABAHOYO.
567. Tal, A., & Wansink, B. (2012). Appetite for Destruction: Hunger Leads to Less Healthy Food Choices. SSRN Electronic Journal.
568. Talwar, D., Sunil, K., Acharya, S., Jagtap, G. S., & Hepat, S. (2021). A Curious Case of Snake Venom Addiction as an Alcohol De-Addiction Tool: Pain for Gain?. Cureus. https://doi.org/10.7759/cureus.19996
569. Tandon, R., Verma, S. K., & Singh, N. (2018). Brainstem and thalamic haemorrhage following cannabis consumption. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2018-135582
570. Tangnitipong, S., Jiranusornkul, S., & Wongrattanakamon, P. (2021). Adverse events related to herbal products used by patients presenting at emergency departments. European Journal of Translational and Clinical Medicine. https://doi.org/10.31373/ejtcm/142816
571. Tao, F., & Li, R. L. (2024). Effects of Cannabis Exposure on Adolescent Health and Development: A Narrative Review. Current Drug Research Reviews. https://doi.org/10.2174/0125899775273727231224185028
572. Tayade, D., Raut, P., & Kolhe, O. (2021). The Pharmacological Study of Caffeine: An Overview. Research & Review Drugs and Drugs Development.
573. Tegin, G., Mekala, H. M., Sarai, S. K., & Lippmann, S. (2018). E-Cigarette Toxicity?. Southern Medical Journal. https://doi.org/10.14423/smj.0000000000000749
574. Teixeira, F. M. C., Costa, L. D. O., & Monteiro, B. M. D. M. (2021). Síndrome de hiperemese secundário ao uso de cannabis: relato de caso / Syndrome of hyperemesis secondary to cannabis use: case report. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n1-226
575. Tellioğlu, T., & Çelebi, F. (2014). Synthetic Marijuana: A Recent Turmoil in Substance Abuse. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. https://doi.org/10.5455/bcp.20141120022005
576. Tenenbein, M. (1997). Leaded gasoline abuse: the role of tetraethyl lead. Human & Experimental Toxicology. https://doi.org/10.1177/096032719701600411
577. Thakur, N., Durrany, A., Kumar, M., Bajwan, D., & Kumar, D. (2024). Dark Side of Cannabis: Impact on Mental Health and Rising Abuse. https://doi.org/10.20944/preprints202407.1358.v1
578. Thamotharan, S., & Conrad, S. M. (2015). Gender‐responsive considerations for substance‐using adolescent girls. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30085
579. Thomes, P. (2021). Natural Recovery by the Liver and Other Organs After Chronic Alcohol Use. Alcohol research. https://doi.org/10.35946/arcr.v41.1.05
580. Thouvenin, B. (2012). Coca et cocaïne : de l'usage traditionnel à l'addiction. HAL (Le Centre pour la Communication Scientifique Directe).
581. Tinawi, M. (2022). Severe Rhabdomyolysis Due to Strenuous Exercise With a Potential Role of a High-Caffeine Energy Drink. Cureus. https://doi.org/10.7759/cureus.20867
582. Tomaselli, G. (2020). Role of pregnenolone derivative AEF0117 on the regulation of CB1 signaling that mediates behavioral effects of THC. HAL (Le Centre pour la Communication Scientifique Directe).
583. Toro, F. V., & Ruiz‐Fernández, M. D. (2016). Alcohol y tabaco en la población joven y su efecto en el árbol vascular. Revista de Estudios de Juventud.
584. Torpy, J. M., Lynm, C., & Glass, R. M. (2006). Dyspepsia. JAMA. https://doi.org/10.1001/jama.295.13.1612
585. Torre, C. L. A. D. L., Suárez, R. D., García, J. C., & Denis, Y. A. (2008). Es el tratamiento farmacológico aislado una buena opción para el tabaquismo. Psiquiatria.com.
586. Torres, F. M. (2009). Caffeine - Induced Psychiatric Disorders.
587. Torres, V. A., Cohen, L. M., & Gulliver, S. B. (2020). Tobacco Use Disorder and Its Treatment. The Wiley Encyclopedia of Health Psychology. https://doi.org/10.1002/9781119057840.ch156
588. Towner, T. T., & Varlinskaya, E. I. (2020). Adolescent Ethanol Exposure: Anxiety-Like Behavioral Alterations, Ethanol Intake, and Sensitivity. Frontiers in Behavioral Neuroscience. https://doi.org/10.3389/fnbeh.2020.00045
589. Tran, A. N., & Ishino, R. (2021). Antidepressants: Is a higher dose always better?. Current psychiatry. https://doi.org/10.12788/cp.0102
590. Trejo, C. A., Cisneros, J. T. C. N., & Vera, N. J. J. (2015). Â¿EL USO DE LAS DROGAS AFECTA A LA SOCIEDAD O â€œCONTRIBUYE AL TURISMOâ€ ? Y SUS RIESGOS EN LOS JÃ“VENES Y ADOLESCENTES. Contribuciones a las Ciencias Sociales.
591. Treviño, V., & Esmeralda, M. (2016). Factores de riesgo para el consumo de tabaco en la adolescencia: Estado Tamaulipas, México.
592. Tripković, M., Frančišković, T., Marković, H., Paradžik, L., & Andric, A. (2014). Alcohol consumption among adolescents in the City of Zagreb and the presence of alcohol drinking among their parents. Alcoholism and psychiatry research Journal on psychiatric research and addictions.
593. Uddin, M. S., Sufian, M. A., Hossain, M. F., Kabir, M. T., Islam, M. T., Rahman, M. M., & Rafe, M. R. (2017). Neuropsychological Effects of Caffeine: Is Caffeine Addictive?. Journal of Psychology & Psychotherapy. https://doi.org/10.4172/2161-0487.1000295
594. Urbańska, M., Ratajczak, L., & Witkowska-Nagiewicz, A. (2012). [Analysis of knowledge about tobacco smoking influence on skin condition].. PubMed.
595. Urszula, J. W., Rafałowicz, A., & Zajkowska, I. (2025). Caffeine as an Ergogenic Aid: A Literature Review of Mechanisms of Action, Performance Effects and Safety Thresholds. Quality in Sport. https://doi.org/10.12775/qs.2025.43.61460
596. Vallez, M. (2013). Vers une dépénalisation du cannabis.
597. Vanderschuren, L. J. M. J., & Everitt, B. J. (2004). Drug Seeking Becomes Compulsive After Prolonged Cocaine Self-Administration. Science. https://doi.org/10.1126/science.1098975
598. Vanjura, M. D. O., Fernandes, D. R., Pontes, L. F. D., Santos, J. C. D., & Júnior, A. T. T. (2018). DROGAS DE ABUSO: MACONHA E SUAS CONSEQUÊNCIAS. Revista Científica FAEMA. https://doi.org/10.31072/rcf.v9iedesp.630
599. Verhaegen, A., & Gaal, L. V. (2017). Do E‐cigarettes induce weight changes and increase cardiometabolic risk? A signal for the future. Obesity Reviews. https://doi.org/10.1111/obr.12568
600. Verster, J. C., Aufricht, C., & Alford, C. (2012). Energy drinks mixed with alcohol: misconceptions, myths, and facts. International Journal of General Medicine. https://doi.org/10.2147/ijgm.s29313
601. Vicol, M., Stîngă, O. C., Caba, L., Ioan, B. G., & Astărăstoae, V. (2013). Drug adiction – it is just a medical problem?. Revista română de bioetică.
602. Vihari, J., Sriteja, N., Pooja, U., Sahu, S., Swain, B., Tammineni, R., Krishna, A. V., Ghosh, S., & Bhuyan, T. B. (2023). Supraventricular tachycardia due to consumption of excessive energy stimulants. Biomedicine. https://doi.org/10.51248/.v43i5.2833
603. Vijayan, M., & Singh, A. (2017). Recreational use of marijuana: Current experience and information for nephrologists.. PubMed.
604. Vlad, R.-A., Hancu, G., Popescu, G. C., & Lungu, I. A. (2018). Doping in Sports, a Never-Ending Story ?. Advanced Pharmaceutical Bulletin. https://doi.org/10.15171/apb.2018.062
605. Vogel‐Sprott, M. (1997). Is behavioral tolerance learned?. PubMed.
606. Vonasch, A., Clark, C. J., Lau, S., Vohs, K. D., & Baumeister, R. F. (2017). Ordinary people associate addiction with loss of free will. Addictive Behaviors Reports. https://doi.org/10.1016/j.abrep.2017.01.002
607. Vs, M. (2016). How Tobacco and Cannabis Smoking Effects Human Physiology. Research and reviews: journal of nursing and health sciences.
608. Vyas, N., Sonal, M., Rajesh, V., & Suhaj, A. (2012). Inhalant abuse- A rising public health problem. International Journal of Medical Science and Public Health. https://doi.org/10.5455/ijmsph.2013.2.146-152
609. Waddell, J. T., Bartholow, B. D., & Piasecki, T. M. (2022). Changes in affect and alcohol craving during naturally occurring drinking episodes: The role of day-level drinking motives.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000600
610. Waddell, J. T., Sher, K. J., & Piasecki, T. M. (2021). Coping motives and negative affect: An ecological study of the antecedents of alcohol craving and alcohol use.. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000696
611. wahono, Q. L. S. (2021). Bahaya Merokok bagi kesehatan. https://doi.org/10.31219/osf.io/su9qn
612. Walukevich‐Dienst, K., Calhoun, B. H., Fairlie, A. M., Cadigan, J. M., Patrick, M. E., & Lee, C. M. (2022). Using substances to cope with social anxiety: Associations with use and consequences in daily life.. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0000899
613. Wang, C. (2006). Exploring young people's concepts of smoking addiction: Perceived opportunities to try smoking without becoming addicted.
614. Wani, K. A., Andrabi, S. J., Manzoor, J., Qadir, H., & Jan, K. (2023). Cultivation of Cannabis. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-6684-5718-4.ch003
615. Ward, K. D., Klesges, R. C., & Weg, M. W. V. (2001). Cessation of Smoking and Body Weight. https://doi.org/10.1002/0470846739.ch22
616. Warren, G., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2012). Author's reply to: Smoking at diagnosis and survival in cancer patients. International Journal of Cancer. https://doi.org/10.1002/ijc.27743
617. Weinberger, A. H., & Sofuoglu, M. (2009). The Impact of Cigarette Smoking on Stimulant Addiction. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990802326280
618. Weinberger, A. H., Walters, P., Allen, T., Dudas, M. M., Sacco, K. A., & George, T. P. (2008). Treatment of nicotine dependence. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544392.025
619. Weldy, D. L. (2010). Risks of Alcoholic Energy Drinks for Youth. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/jabfm.2010.04.090261
620. Westin, A. A., & Slørdal, L. (2009). Passiv røyking av cannabis – hva skal vi tro?. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.09.33889
621. Westwater, M. L., Ziauddeen, H., & Fletcher, P. C. (2024). Disordered Eating and the Brain. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190671051.003.0060
622. Weuve, J., & Weisskopf, M. G. (2012). CHAPTER 1. Exposure to Lead and Cognitive Dysfunction. Issues in toxicology. https://doi.org/10.1039/9781849734660-00005
623. Wheeler, M. G., Duncan, E., & Davis, M. (2016). Low startle magnitude may be a behavioral marker of vulnerability to cocaine addiction. Synapse. https://doi.org/10.1002/syn.21943
624. White, C. T., Shamim, H., Shouli, R. A., Habbal, A. B., & Mohammed, L. (2022). Cannabis Use and the Development of Depression in Adolescents: Is There an Established Linear Relationship Between the Two?. Cureus. https://doi.org/10.7759/cureus.27394
625. Williams, A. R. (2020). Cannabis as a Gateway Drug for Opioid Use Disorder. The Journal of Law Medicine & Ethics. https://doi.org/10.1177/1073110520935338
626. Williams, K. (2021). Short note on Hangover and its Effects. Journal of Alcoholism and Drug Dependence.
627. Wilson, C. A., Finch, E., Kerr, C. E., & Shakespeare, J. (2020). Alcohol, smoking, and other substance use in the perinatal period. BMJ. https://doi.org/10.1136/bmj.m1627
628. Winhusen, T., Theobald, J., Kaelber, D. C., & Lewis, D. (2019). The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2019.1676433
629. Winistoerfer, N. M. (2012). Clinical Pearl: Levamisole-induced vasculitis with necrosis in chronic cocaine users. Mental Health Clinician. https://doi.org/10.9740/mhc.n109214
630. Winslow, B. T., Onysko, M., & Hébert, M. (2016). Medications for Alcohol Use Disorder.. PubMed.
631. Winters, K. C., & Ingwalson, A. (2022). Overview of Psychoactive Substances. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0004
632. Wit, L. D., Jeurissen, S., & Chen, W. (2021). Risk assessment of herbal preparations containing St John's wort. https://doi.org/10.21945/rivm-2019-0115
633. Wolk, B., Ganetsky, M., & Babu, K. M. (2012). Toxicity of energy drinks. Current Opinion in Pediatrics. https://doi.org/10.1097/mop.0b013e3283506827
634. Woods-Lee, M. C. (2020). Glossary of terms. British Small Animal Veterinary Association eBooks. https://doi.org/10.22233/9781910443828.app1
635. Wouters, M., Beccaria, F., Cottino, A., & Korf, D. J. (2017). Consumption Patterns among Socially Integrated Drug Users. Routledge eBooks. https://doi.org/10.4324/9781315235462-11
636. Wycoff, A. M., Darmour, C. A., McCarthy, D. M., & Trull, T. J. (2024). Event-level influences of alcohol, cannabis, and simultaneous use on perceived driving risk.. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000758
637. Wycoff, A. M., Haney, A. M., Conger, K. B., & Trull, T. J. (2024). Momentary cannabis use motives and associated affective changes in daily life.. Psychology of Addictive Behaviors. https://doi.org/10.1037/adb0001035
638. Wycoff, A. M., Miller, M. B., & Trull, T. J. (2024). Bidirectional associations between sleep and cannabis and alcohol (co‐)use in daily life. Alcohol Clinical and Experimental Research. https://doi.org/10.1111/acer.15448
639. Wylie, B. J., Hauptman, M., Hacker, M. R., & Hawkins, S. S. (2021). Understanding Rising Electronic Cigarette Use. Obstetrics and Gynecology. https://doi.org/10.1097/aog.0000000000004282
640. Xing, C., Malaty, J., Malham, M. B., Orlando, F. A., Lynch, A. M., Huo, Z., François, M., Firpi-Morell, R., Fisher, C. L., Christou, D. D., & Salloum, R. G. (2024). The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-024-04722-9
641. Yadav, H., Sankhla, M. S., Kumar, R., & Sankhla, M. S. (2019). Youth Becoming Addict of Cannabis and its Advancement at the Cost of Health. ARC Journal of Forensic Science. https://doi.org/10.20431/2456-0049.0401002
642. Yafai, S. (2023). An Antidote for THC Overdose?. Emergency Medicine News. https://doi.org/10.1097/01.eem.0000978628.45757.4e
643. Yamane, S., Yoneda, H., Takahashi, T., Kamijo, Y., Komori, Y., Hiruma, F., & Tsutsui, Y. (2011). Smokers, Smoking Deprivation, and Time Discounting. https://doi.org/10.11167/jbef.4.111
644. Yarnell, A. M., & Deuster, P. A. (2016). Caffeine and Performance. Journal of Special Operations Medicine. https://doi.org/10.55460/wknd-5j8w
645. Yeruva, R. R., Mekala, H. M., Sidhu, M., & Lippmann, S. (2019). Synthetic Cannabinoids-"Spice" Can Induce a Psychosis: A Brief Review.. PubMed.
646. Yeterian, J. D., Bursik, K., & Kelly, J. F. (2018). “God Put Weed Here for Us to Smoke”: A Mixed-Methods Study of Religion and Spirituality among Adolescents with Cannabis use Disorders. Substance Abuse. https://doi.org/10.1080/08897077.2018.1449168
647. Zacny, J. P. (1990). Behavioral aspects of alcohol-tobacco interactions.. PubMed.
648. Zagorski, N. (2019). Medications May Ease Cannabis Withdrawal But Fail to Achieve Abstinence. Psychiatric News. https://doi.org/10.1176/appi.pn.2019.6b18
649. Zakiyah, Z., Sihombing, Y. A., Kamaruddin, M. I., Salomon, G. A., & Anshari, M. (2023). Stress Level and Smoking Behavior. JURNAL ILMIAH KESEHATAN SANDI HUSADA. https://doi.org/10.35816/jiskh.v12i2.1118
650. Zhang, C., Zhang, H., Zhang, B., Lindenberg, J., Amat, M. J., Rice, M. B., & Mukamal, K. J. (2024). Marijuana Use and Hemoglobin Concentrations in NHANES 2009-2018: Implications for Subclinical Hypoxemia. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.202404-357oc
651. Ziedonis, D., Steinberg, M. L., Fiester, S. J., Cimpeanu, C., & First, M. B. (2008). Substance Abuse: Nicotine Dependence. Psychiatry. https://doi.org/10.1002/9780470515167.ch62
652. Zothantluanga, J. H., Lalnunpuii, H. S., Bhat, H. R., & Shakya, A. (2020). Awareness on the possible adverse effects of Garcinia cambogia: A scientific approach. Science Vision. https://doi.org/10.33493/scivis.19.04.02
653. Zuñiga, R. M. B., & Márquez, S. B. (2017). Campañas de acción social: Impactos en el estereotipo hacía el consumidor de marihuana.. info:eu-repo/semantics/bachelorThesis.
654. Özkan, M., & Oto, R. (2001). İnhalanla İlişkili Bozukluklar.
655. Özyürek, D., Çolaklar, M., Canik, B., Kocakır, E., Seyhan, E., Gürlek, E., Yaşar, F., Demircioğlu, İ. G., Kahya, H. H., Orhan, İ. G., Çakmak, M., Uğurlu, N. M., Koyuncu, Ş. N., Bozan, Ş. M., Altın, Y. F., Çotur, Z., Yardim, M. S., & Özcebe, H. (2019). BİR TIP FAKÜLTESİ İNTERN DOKTORLARININ SİGARA İÇME DAVRANIŞLARI VE İLİŞKİLİ FAKTÖRLER. 3.International 21.National Public Health Congress.
656. ČERNÝ, L., & ČERNÝ, K. (1992). Can carrots be addictive? An extraordinary form of drug dependence. British Journal of Addiction. https://doi.org/10.1111/j.1360-0443.1992.tb02007.x
657. ̌Simovic, M. N. (2022). RIZIČNA PONAŠANJA ADOLESCENATA I MJERE PREVENCIJE. DRUŠTVENE DEVIJACIJE. https://doi.org/10.7251/zcmz0122037s